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ABSTRACT
Numerous studies have reported aberrant gene expression levels attributed to
suboptimal in vitro culture conditions presented to embryos. Since the culture environment is a
common aspect of both in vitro production (IVP) and nuclear transfer (NT), research focusing on
the in vitro culture system will have the potential to improve both techniques. This study
investigated the effects of different culture systems and protein sources on the developmental
competence of IVP embryos measured by cleavage and blastocyst rates, cell number, and
relative abundance of oct-4, nanog, connexin 43, and GLUT-1 transcripts when compared to in
vivo embryos. Experiment 1 compared IVP embryos cultured in either synthetic oviductal fluid
(SOFaa) or potassium simplex optimized medium (KSOMaa) supplemented with amino acids.
Experiment 2 compared the same two culture systems with and without the addition of calf
serum (CS). Results from both experiments indicated that despite similar developmental rates,
significant differences were observed at the mRNA level. In Experiment 1, oct-4 was the only
transcript to have a mean abundance level significantly higher in KSOMaa blastocysts when
compared with both SOFaa and in vivo embryos. The same pattern of upregulation of oct-4 in
KSOMaa or KSOMaa with CS blastocysts was noted in Experiment 2. There were no significant
alterations of the ICM specific transcript nanog in either experiment. In contrast to reports by
others, connexin 43 was not expressed at detectable levels in in vivo embryos analyzed in our
studies. Connexin 43 was not detected in IVP blastocysts used in Experiment 1. Connexin 43
was detected in KSOMaa, SOFaa, and SOFaa with CS blastocysts in Experiment 2. Blastocysts
cultured in SOFaa with CS or KSOMaa had a significant upregulation of GLUT-1 when
compared with other treatments and in vivo embryos. Overall, the transcript levels of the
majority of the genes analyzed were significantly altered by an in vitro culture condition.
Differences continue to be observed between in vitro cultured and in vivo embryos, and until
these differences are minimized, aberrations in in vitro development will continue to arise.
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CHAPTER I
INTRODUCTION
The advent of in vitro production (IVP) (or in vitro fertilization – IVF) and nuclear transfer
(NT) of bovine embryos has introduced alternate methods to conventional superovulation
techniques (Bavister, 1995). IVP embryonic development is dependent on oocyte maturation,
fertilization and subsequent culture. In particular, the 5 to 6 day post fertilization period of IVP
embryos is the time during which various developmentally important events occur including the
first cleavage division, activation of embryonic genome (Memili and First, 2000), compaction of
the morula, and blastocyst formation (Tesfaye et al., 2004).
NT offers the ability to precisely manipulate the genome of livestock resulting in offspring
with predetermined genetic modifications. However, the success of NT is very low with only 0.2
to 3.4% of manipulated embryos resulting in cloned offspring with few exceptions (Yanagimachi,
2002).
The inefficiency of these biotechnologies is likely related to the abnormal gene
expression levels seen in these manipulated embryos. Previously proposed hypotheses for the
aberrant gene expression observed in these embryos/offspring include: abnormal expression of
transcription factors, epigenetic effects such as DNA methylation, reprogramming of the somatic
cell nucleus, chromatin remodeling, and a particular hypothesis of our laboratory which focuses
on the embryo culture environment. A great deal of research has been dedicated to embryo
culture conditions. However, no one particular culture environment has been determined to be
the best or optimal medium. We hypothesize that it is a suboptimal culture medium that is
initiating abnormal transcript levels in bovine IVF embryos. Therefore, we feel that there is still
much to learn about embryonic culture conditions and the knowledge that can be gained from
these experiments will lead to a better understanding of the bovine embryo culture environment.
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Most experiments determine developmental competency of embryos simply by utilizing
morphological evaluations such as cleavage rates, blastocyst rates, or less frequently cell
number data. While these endpoints are useful, they fail to accurately determine viability of the
embryo post transfer into a recipient. The only true measure of viability is evident by the
production of a healthy offspring. More quantitative measurements such as polymerase chain
reaction (PCR) that measures gene expression levels in embryos should enable a more detailed
picture of developmental competence than simple morphological assessments. Numerous
studies have detected aberrant expression levels attributed to suboptimal culture conditions
(Wrenzycki et al., 1996, 1999, 2001, 2004; Eckert and Niemann, 1998; Lazzari et al., 2002;
Rizos et al., 2002, 2003; Lonergan et al., 2003). Therefore, we believe that PCR analysis of
suitable candidate genes for developmental competence would be a valuable tool to test a
select group of embryos prior to transfer.
The overall goal of our research is to increase the efficiency of embryo biotechnologies
through a better understanding of the transcriptional mechanisms controlling gene expression in
bovine embryos. More specifically, we hope to determine if alterations to current culture
conditions will affect gene expression and/or make embryo biotechnologies more proficient. The
results of these studies may formulate a more suitable embryo culture environment for
manipulated bovine embryos.
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CHAPTER II
LITERATURE REVIEW
Mammalian Embryonic Development
Embryogenesis, the period from fertilization to implantation, involves various
morphological, cellular, and biochemical changes related to genomic activity. Embryonic cells
undergo both proliferation and differentiation processes to form the fetus and placental tissues
throughout early embryogenesis. After fertilization, embryonic development involves protein
synthesis, proliferation, differentiation, and the formation of fetal and extra-embryonic tissues.
During this period, various changes take place with a genetic contribution to the fetus. Such
events lead to morphologic elongation of embryonic tissues, cell-cell contact between the
mother and the embryo/fetus, and placentation (reviewed by Ushizawa et al., 2004). It is
assumed that a network of regulatory genes controls the transformation of genetic information
from the parental source to the embryo (Scholer et al., 1989). However, the exact mechanisms
for this transfer are not clear for mammalian embryogenesis.
Early embryonic development in many species is primarily supported by maternal RNAs
and proteins synthesized during oogenesis. As development proceeds these proteins degrade,
and embryogenesis becomes solely dependent on embryonic derived genes. Transcriptional
activation of the embryonic genes is the result of a gradual degradation of the maternal RNAs
and proteins due to the reprogramming of the cell nucleus (Memili and First, 2000). This
transition period sets the stage for later stages of embryonic development and is normally
initiated at the 8- to 16-cell stage in the cow (Kopency et al., 1989). However, recent reports
indicate that the transition may occur slightly earlier in development.
In vitro embryo development is dependent on oocyte maturation, fertilization and
subsequent culture. Although cleavage of the embryo is an indicator of development, the very
early stages of development are largely supported by the cytoplasm of the oocyte. In particular,
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the 5 to 6 day post fertilization period of in vitro production (IVP) of embryos is the time when
various developmentally important events occur including the first cleavage division, which is
critical in determining the subsequent development of the embryo (Lonergan et al., 1999),
activation of the embryonic genome (Memili and First, 2000) or the maternal to zygotic
transition, compaction of the morula, which involves the establishment of the first cell-to-cell
contacts within the embryo, and blastocyst formation which is the time point of the first
differentiation into two cell types the trophectoderm and the inner cell mass (ICM). This time
period is generally referred to as the pre-implantation period. This period is characterized by
distinct morphological steps that must include a well-orchestrated expression of genes derived
from both the maternal and embryonic genomes to allow for compaction, cavitation, and
blastocoel expansion (Kidder, 1992). After the pre-implantation period, the trophectoderm in
ruminant animals will elongate exponentially reaching > 150 mm before the embryo will
eventually implant in the uterine wall (Degrelle et al., 2005). Clearly any modifications to the in
vitro culture environment can have profound effects on the quality of the resulting embryos
measured in terms of cryotolerance and relative transcript abundance (Lonergan et al., 2003).
IVP of bovine embryos has become a reliable alternative method to conventional
superovulation induction techniques and has been used as a tool to study pre-implantation
embryo development (Bavister, 1995). However, little thought is often given to what implications
could arise from using artificial technologies in terms of its effects on gene expression.

Abnormalities Observed in Pre-implantation Development
IVP versus NT Embryos
Somatic cell nuclear transfer (SCNT) or cloning allows researchers to precisely
manipulate the genome of livestock. The resulting embryos can be transferred to female
recipients and the resulting progeny will harbor the predetermined genetic modification
(Schnieke et al., 1997; Cibelli et al., 1998). Cloned offspring have been reported in several
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species, including the sheep (Wilmut et al., 1997), mouse (Wakayama et al., 1998), cow (Kato
et al., 1998; Wells et al, 1999), goat (Baguisi et al., 1999; Keefer et al., 2001), pig (Onishi et al.,
2000; Polejaeva et al., 2000), cat (Shin et al., 2002), and horse (Galli et al., 2003). The rate of
success in development to term for these cloned offspring are extremely low (0.2%-3.4% of
reconstructed oocytes) with a few exceptions (Boiani et al., 2002; Yanagimachi, 2002),
particularly in the mouse with less than 3% of reconstructed oocytes surviving to term
(Wakayama and Yanagimachi, 1999). Approximately 80 to 90% of immature bovine oocytes
undergo successful nuclear maturation in vitro, of which 80% undergo fertilization, 30 to 40%
develop to the blastocyst stage, and around 40% of the transferred embryos establish and
successfully maintain a pregnancy (Hasler et al., 1995). Therefore, IVP is more efficient than
NT, but substantial losses are observed. Most of the losses in IVP seem to be during the in vitro
culture stages (between the 2-cell and blastocyst stages) suggesting that the post-fertilization
environment is the most critical period of development in terms of determining blastocyst yield
(Lonergan et al., 2006).
Offspring produced by in vitro means and somatic cell nuclear transfer (SCNT) have
been affected by numerous genetic abnormalities in particular, “large offspring syndrome”
(LOS). These offspring are derived from in vitro produced embryos, including IVF and NT, which
are subsequently transferred into recipient animals. It is thought that an extended in vitro culture
may contribute to LOS. This syndrome is characterized by a variety of phenotypes in the
newborn including significant increases in birth weight, polyhydramnios, hydrops fetalis,
breathing difficulties, reluctance to suckle, altered organ growth, various skeletal and placental
defects, immunological defects, and increased perinatal death (reviewed by Young et al., 1998).
Some of these defects, such as increased organ growth, can persist into adulthood (Lonergan
et al., 2006). LOS has also been attributed to an increase in embryonic/conceptus losses,
particularly during the first trimester of pregnancy (Zhang et al., 2004).
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Recent studies of NT embryos during pre-implantation development have revealed
striking defects indicating that cloned embryos fail to recapitulate many of the events essential
to normal development (Mann et al., 2003). Blastocyst stage cloned embryos from several
species tend to have fewer cells than normal blastocysts (Koo et al., 2000, 2002; Chesne et al.,
2002; Chung et al., 2002). Even though mammalian blastocysts have some plasticity in their
ability to compensate for this variation in cell number, they do not develop at a normal frequency
when the cell number is drastically reduced (Boaini et al., 2003). The oocyte enucleation and
donor cell transfer (either somatic or stem cells) procedures themselves may result in the
production of cloned embryos with inappropriate gene expression levels. Such alterations are
probably the primary cause of embryonic loss in NT (Ushizawa et al., 2004). However, most
studies have been limited to the few, rare, surviving clones that reach fetal, neonatal, or adult
stages of development (Mann et al., 2003). Studies of gene expression levels have been
conduced in fetuses, live young, placenta, and of course in pre-implantation embryos (Boiani et
al., 2002; Mann et al., 2003; Ecker et al., 2004). Successful cloning can only be expected when
proper recapitulation of the normal embryonic pattern of gene expression is established (Mann
et al., 2003).
Differences in gene expression patterns between IVP and NT derived embryos when
compared to in vivo embryos may originate from all steps of the manipulation process: in vitro
maturation (IVM), in vitro fertilization (IVF), in vitro culture (IVC), and for NT embryos from
different NT protocols (Wrenzycki et al., 1996, 1998, 2001 and 2004). Specifically, cloned
embryos have a disadvantage in survival rate compared to IVP embryos because of the multiple
potential causes for abnormal gene expression due to the inability of cloned embryos to
recapitulate many of the essential events of normal development (see Table 2.1). When
compared to NT, IVP embryo gene expression levels appear to be more analogous to their in
vivo equivalents.
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Table 2.1. Normal versus Cloned Embryos
Stage
Normal Embryos

Cloned Embryos

Gametogenesis

Genome “competent” for
activation of “early” genes,
establishment of imprints

None

Cleavage

Global demethylation Activation
of embryonic (“oct-4-like”) genes

Post-implantation

Postnatal

Abnormal methylation
Random/faulty activation of “oct4-like” genes
Global de novo methylation, X-inactivation, telomere length
adjustment (post-zygotic events)

Normal imprinting and gene
expression

Abnormal imprinting, global gene
dysregulation

Normal animal

Large offspring syndrome,
premature death

(reviewed by Jaenisch et al., 2004)
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Aberrant gene expression in NT embryos/offspring may be caused by abnormal
expression of transcription factors (Memili and First, 2000), epigenetic effects such as DNA
methylation (Cezar et al., 2003), incomplete reprogramming of the somatic cell nucleus (Boiani
et al., 2003), chromatin remodeling (Kim et al., 2002), and a particular hypothesis of our
laboratory which focuses on the embryo culture environment. NT embryos tend to prefer culture
medium conditions more like somatic cell characteristics indicating a lack of nuclear
reprogramming which affects basic physiology and metabolism (Mann et al., 2003). However,
these are just some of the speculations. As mentioned before, the mechanisms are still not
completely understood.
Possible Origins of Abnormal Gene Expression Levels
Transcription factors are proteins that bind to the DNA and either activate or repress
transcription of specific genes (Chau et al., 2002). Thus, transcription factors are the key
regulators of gene expression in cells. Transcriptional control in the various differentiated cell
types allows each type of cell (e.g., epithelial, muscle, neuron) to express different amounts of
the possible proteins. The transcription factors are regulated by signal transduction pathways
that relay signals from outside of cells to the cell nucleus (Gilbert, 2003). As stated before,
embryonic transcription is initiated at the 8- to 16-cell stage in cattle. However, recent reports
indicate that embryonic transcription may be as early as the 2-cell stage (Memili and First,
2000). Nevertheless, embryos can survive without embryonic transcription until a certain stage
of development. The embryo relies on the maternal mRNA source for genetic information until
the point of the maternal to zygotic transition. This generally occurs around the 8-cell stage in
cattle.
This transition is sometimes referred to as the “block to development” because under
suboptimal culture conditions, embryos often do not develop past this point. This block suggests
that embryonic transcription is particularly sensitive to the culture conditions presented to the
embryo (Memili and First, 2000). It has also been suggested that the developmental block could

8

be alleviated by co-culture systems, addition of fetal calf serum to the medium, or a reduction of
glucose in the medium (Gandolfi and Moor, 1987). After this transition point, the embryo relies
on its own transcription factors necessary for the production of RNA. Memili and First (2000)
and others reported that there is a low level of transcription activation termed the ‘minor gene
activation’ between the 1- and 4-cell stages and a high level of gene activation termed the
‘major gene activation’ at the 8-cell stage in bovine embryos (See Figure 2.1). Figure 2.1
illustrates the importance and necessity of precise timing of the activation of gene expression
via the presence of transcription factors. Under or over-expression of these transcription factors
in NT embryos prevents the binding of the promoter to the DNA allowing the start of
transcription. For example, the POU domain proteins include a family of transcription factors
crucial to development and cell differentiation, particularly in murine embryo development
(Kirchhof et al., 2000). This domain is characterized by the presence of DNA-binding sites of 81
and 60 conserved amino acids and includes mammalian transcription factors Pit-1, Oct-1, Oct-2,
Oct-3, and oct-4 in various species (Yeom et al., 1991). Abnormal embryonic development has
been linked to both upregulations and downregulations of these transcription factors.
Epigenetics is the alteration in gene function and expression that cannot be explained by
the DNA sequence, but rather are explained by structural modifications of the chromatin
(reviewed by Jaenisch et al., 2004). It is likely that epigenetic changes occurring in differentiated
somatic cells contribute to incomplete or faulty reprogramming during nuclear transfer. DNA
methylation, a primary epigenetic modification, involves the addition of methyl groups to the
cytosine residues found in CpG motifs. DNA methylation plays a critical role in controlling the
expression of a particular gene. Increased methylation inhibits transcription, a situation
commonly found in differentiated somatic cells while embryonic cells are usually undermethylated. For example, elevated insulin-like growth factor-2 (IGF-2) concentrations are
associated with large offspring syndrome in sheep and mice. This altered gene expression is
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Figure 2.1. Bovine embryonic cell cycles and zygotic/embryonic gene expression (mRNA
synthesis) in cattle. The cell cycle was adapted from Barnes & Eyestone (1990). Data suggests
that there is a ‘minor gene activation’ between the 1- and 4-cell stages. Changes in the
transcriptional machinery and chromatin structure play an important role in the control of early
gene expression. Several references reviewed suggest there is a ‘major gene activation’ starting
at the 8-cell stage (Memili and First, 2000).

10

linked with decreased DNA methylation in these species (Eggenschwiler et al., 1997; Young et
al., 2001). Methylation patterns in NT embryos differ from those of IVP controls (Cezar et al.,
2003). Cezar and associates (2003) were the first to find that NT-generated fetuses have overall
decreased levels of methylated cytosines, suggesting a hypomethylated genome when
compared with in vivo produced fetuses. Conversely, there was no significant difference in
methylation patterns between in vitro and in vivo produced embryos in this same study. The
mechanism behind these methylation patterns is unclear. It is unknown to what extent that DNA
methylation, which occurs in normal development, needs to be mimicked for NT to be
successful (Cezar et al., 2003).
A favored hypothesis for the developmental incompetence of clones is inadequate
reprogramming of the transplanted somatic cell nucleus to an equivalent state of an early
nucleus in the developmental process (Boiani et al., 2002). Reprogramming, in the context of
SCNT, can be defined as the transformation of a somatic cell nucleus into a functional
embryonic nucleus capable of forming a viable organism. For the successful development of a
reconstructed NT embryo, a transferred nucleus must undergo reprogramming to establish the
temporal and spatial gene expression patterns associated with normal development (Cezar et
al., 2003). “Correct” expression of embryonic genes is essential for development and is
indicative of nuclear reprogramming (Boiani et al., 2003). Several studies have shown that
changes in the nuclear material prior to transcription include: nuclear swelling, dispersal of
nucleoli, nuclear envelope breakdown, and premature chromosome condensation.
Comprehensive changes in transcriptional activity of these transplanted nuclei also have
been detected (Boiani et al., 2002). One way to address the ability of cloned embryos to
undergo genetic reprogramming is to determine the fate of imprinted gene modifications during
clonal development. Mann et al. (2003) examined gene imprinting during the earliest stages of
clonal development to determine how epigenetic information in cloned embryos may be
affected. They analyzed allele-specific expression of imprinted genes in cloned mouse
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blastocysts and found widespread defects in imprinted gene regulation at all three levels of
expression: total transcript abundance, allele specificity of expression, and allelic DNA
methylation. The results indicated that only ~ 4% of the NT embryos had normal expression
patterns of the imprinted genes analyzed which may help explain the low efficiency of mouse
cloning. From these results, it is clear that several of the questions regarding nuclear
reprogramming of the somatic cell have yet to be answered.
Nuclear reprogramming is generally preceded by chromatin remodeling. One component
of chromatin remodeling is the breakdown of the nucleosome consequently permitting access to
the chromatin and allowing for transcription and gene expression (reviewed by Becker, 2004).
Silencing of transcription versus the accumulation of TATA box binding protein and the
loosening of chromatin structure are important events in chromatin remodeling. The failure of
oocytes to successfully accomplish these events results in inadequate somatic nuclei
remodeling in NT embryos, thus leading to abnormal development in NT offspring (Kim et al.,
2002). As a result, nuclear reprogramming is much more successful when the chromatin
structure is unwrapped allowing more accessibility to the chromosomes (Piedrahita et al., 2004).
The direct exposure of chromosomes to the cytoplasm is thought to be important in somatic
nuclei remodeling to support further development. High levels of maturation promoting factor
(MPF) in enucleated Metaphase II (MII) or mature oocytes induces the breakdown of the
germinal vesicle and chromosome condensation (actually premature chromosome
condensation) within the oocyte. When activation is stimulated in the oocyte, the MPF levels
decrease allowing chromosome decondensation and formation of the pronucleus. The timing of
these events is critical for optimum chromatin remodeling. Altered timing is primarily due to the
origin of the host cytoplast in NT-produced embryos (Campbell et al., 1996; Choi et al., 2004).
In addition to the mechanisms of transcription described above, other factors that may
be involved in the observed abnormal development of NT clones could include: pre-implantation
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and post-implantation development, effects of micromanipulation, oocyte activation, and in vitro
culture (Boiani et al., 2002).

In Vitro Culture Conditions and Abnormal Gene Expression Levels
While it is the intrinsic quality of the oocyte that will determine whether or not that oocyte
will develop to a blastocyst, it is the post fertilization culture environment that has the biggest
influence on blastocyst quality regardless of oocyte origin (Rizos et al., 2003). The postfertilization culture environment encompasses not only the culture medium itself but also the
number of embryos cultured together, the embryo: medium ratio, any supplementation used, the
temperature, and the gas atmosphere. The relative abundance of numerous transcripts varies
through the early pre-implantation period and is strongly influenced by the culture environment
(Wrenzycki et al., 1996, 1999, 2001, 2004; Eckert and Niemann, 1998; Lazzari et al., 2002;
Rizos et al., 2002, 2003; Lonergan et al., 2003). The effects of a suboptimal culture environment
on the embryo are mediated through modifications of the gene expression levels in the resulting
embryos. Differences in gene expression patterns are sometimes apparent at very early
cleavage stages, in some cases only after one day of in vitro culture implicating the temporal
association between the culture environment and expression patterns (Rizos et al., 2002, 2003).
Most of the time, the effects are apparent at later stages of development resulting in a lack of
blastocyst formation or abnormal development (Tesfaye et al., 2004). These changes in the
transcript abundance measured in blastocyst stage embryos are likely the result of disturbed
expression earlier in embryo development (Lonergan et al., 2003).
Suboptimal culture conditions may result in abnormal embryonic, fetal, perinatal, and
postnatal development, collectively referred to as LOS described above (Young et al., 1998;
reviewed by Wrenzycki et al., 2004). Current culture systems can also lead to either persistent
silencing or enhanced expression of a particular gene throughout the critical phases of fetal
development (Wrenzycki et al., 2001). A higher expression of a particular gene under in vitro
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culture conditions when compared to in vivo embryos can be considered as a response of the
embryo to the suboptimal culture condition or that the gene was induced as a result of the in
vitro culture condition. An extended in vitro culture of bovine pre-implantation embryos has been
shown to perturb the well organized and executed gene expression pattern essential for normal
development (Wrenzycki et al., 1996, 1998). A prolonged in vitro culture of early sheep embryos
resulted in several abnormalities including: cytoplasmic fragmentation, premature blastocoel
formation, and a reduced number of nuclei per blastocyst (Walker et al., 1992). Rizos et al.
(2002) found clear differences in the level of expression of several developmentally important
gene transcripts when bovine embryos were cultured in different media. More specifically,
blastocysts produced following culture in synthetic oviductal fluid (SOF), a medium designed for
the demands of the pre-implantation embryo, have significantly altered patterns of genes
involved in gap junction formation, apoptosis, oxidative stress and differentiation compared to
their in vivo counterparts. Ho et al. (1995) reported that in the mouse, the optimized cell culture
potassium simplex optimized medium (KSOM) supplemented with amino acids or serum
provided very similar expression profiles (almost identical) as those found in in vivo embryos.
Enright et al. (2000) reported that the culture of in vitro produced bovine zygotes in the well
established ewe oviduct model can dramatically increase their cryotolerance to a level similar to
that of totally in vivo produced embryos. The ligated ewe oviduct has been reported to support
the growth and development of both bovine (Eyestone et al., 1987) and porcine embryos
(Prather et al., 1991). This ability to support embryonic development utilizing a “semi-in vivo”
model has been used extensively in IVP systems where embryos are allowed to co-culture with
oviduct epithelial cells (Eyestone and First, 1989; Moore and Bondioli, 1993).
Typically, most culture media used in embryo culture systems are supplemented with
either serum or bovine serum albumin (BSA) as a protein source. However, these undefined
complex mixtures result in highly variable developmental rates and/or mRNA expression levels
and are often contaminated with various small peptides, energy substrates, or growth factors
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(Bavister, 1995). Different protein sources in culture medium can greatly influence development
of IVP embryos, ranging from either a marked stimulation in some aspects to a significant
inhibition of other processes. In fact, the quality of serum and BSA can vary greatly depending
on the source and specifically for serum, the lot number (Bavister, 1995). Serum has been
shown to have a biphasic influence on the developmental capacity of bovine embryos by
inhibiting the first cleavage division but enhancing later blastocyst development (Wrenzycki et
al., 1998). Serum can affect the speed of embryo development and the resulting quality of the
embryos produced (Rizos et al., 2003). Serum supplementation between 5% and 20% was
shown to increase blastocyst production rates when compared to BSA supplementation
(Lonergan, 1999). Serum supplementation has also been linked to a high incidence of apoptosis
in IVP blastocysts (Gjorret et al., 2001). The presence of serum in tissue culture medium (TCM)
199, which is a complex media designed for cell culture, over a prolonged period of time has
also been shown to alter the expression pattern of various genes (Wrenzycki et al., 1999),
embryo morphology, and biochemistry (Rizos et al., 2003). In contrast, Lonergan et al. (2003)
showed that simply omitting serum from the culture medium during the post-fertilization period
changed mRNA abundance for several developmentally important genes. Most report that the
majority of genes are upregulated in the presence of serum. In contrast, Wrenzycki et al. (1999)
found that the majority of the genes they studied were upregulated in polyvinyl alcohol (PVA), a
synthetic macromolecule, when compared to their serum-generated counterparts. In addition,
Barcelo-Fimbres and Seidel (2007) reported that a serum-free culture did not affect blastocyst
yield. Therefore, differences are only detectable at the transcript level. Omission of serum can
also significantly improve the cryotolerance of the blastocysts to a level intermediate between
serum supplemented blastocysts and in vivo derived blastocysts (Rizos et al., 2003). This
observation also supports that hypothesis that serum affects developmental competence at the
transcript level. There also is a positive correlation between high serum content, in particular
with fetal calf serum (FCS), added to a medium with LOS in the resulting offspring (Thompson
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et al., 1995). FCS is a good source of nutrients and anti-oxidants for the embryo. On the other
hand, because of its association with LOS, altered metabolism, excess lipid accumulation,
abnormalities of organelles, premature blastulation, and altered gene expression levels, the
efficacy of FCS is under investigation (Barcelo-Fimbres and Seidel, 2007). Serum is often
replaced by BSA, a more defined protein source when compared to serum (Wrenzycki et al.,
1998). Often these less defined components are replaced by a synthetic macromolecule known
as PVA resulting in a defined media composition. However, PVA is not a true protein source but
rather just reduces the surface tension of the media. PVA is believed to be metabolically inert to
the embryo and is less able to support embryo development (Kane and Bavister, 1988;
Wrenzycki et al., 2001).
Wrenzycki and coworkers (2001) were the first to report of the effects of two different culture
systems TCM199 or SOF containing either serum, BSA, or PVA on the relative levels of several
gene transcripts in bovine morulae and blastocysts involved in cellular compaction, metabolism,
RNA processing, stress, and maternal recognition. No significant difference was found in the
embryonic developmental rate for the different treatments, but significant differences were
observed at the transcript level. The basic culture system itself whether in vivo or in vitro had
profound effects on transcript levels, while the individual protein source had only weak effects
on abundance levels. It was also determined that the morula stage was more susceptible to
aberrations in gene expression than the blastocyst stage indicating that the morula stage could
be an indicator when testing culture media for suitability (Wrenzycki et al., 2001).
Another key component of culture media that has been shown to affect post fertilization
events is the energy substrate chosen. Generally simple energy sources such as pyruvate are
preferred early in development, while more complex energy sources such as glucose or fructose
are preferred substrates after the morula stage. It is a well accepted fact that glucose plays an
important role in embryonic metabolism and is frequently used in most in vitro embryo systems
despite its putative toxic effects to the early embryo (Barcelo-Fimbres and Seidel, 2007).
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Glucose was found to be detrimental to in vitro cultured bovine embryos from the time of
fertilization through the morula stage (Takahashi and First, 1992); however, bovine embryos
cultured after the morula stage preferred glucose as an energy source (Reiger, 1992). The use
of fructose during in vitro culture increased total cell number in hamster embryos (Ludwig et al.,
2001), reduced the amount of fragmented DNA found in nuclei of porcine blastocysts, and
enhanced embryo quality by reducing lipid granule accumulation in bovine embryos (BarceloFimbres and Seidel, 2007). The addition of either fructose or glucose to bovine embryo culture
media improved blastocyst rates per oocyte matured; however, the beneficial effects of fructose
were only apparent after the 8-cell stage (Barcelo-Fimbres and Seidel, 2007). Sucrose addition
to early culture medium lowered the frequency of apoptosis and increased nuclei number in
blastocysts, therefore, improving overall development of pre-implantation porcine NT and IVP
embryos (Hwang et al., 2006).
Pre-implantation embryos are able to develop in vitro in a wide array of culture
conditions. They are able to develop in media ranging in composition from simple balanced salt
solutions to complex systems supplemented with serum and somatic cells (Lonergan et al.,
2006). However, this ability to adapt to the environment presented to the embryo especially
under suboptimal or even nonphysiological conditions comes at a cost to the embryo in terms of
embryo quality (Rizos et al., 2002). Wrenzycki et al. (2004) indicated that when the capacity of
an embryo to compensate for its environment is overloaded, development arrests. To date, no
one culture medium is truly optimal in regards to producing embryos with ideal developmental
rate, cell/nuclei number, temperature sensitivity, freezability, viability, pregnancy rates after
transfer, and gene expression patterns. Aberrant gene expression will continue to arise as long
as embryos continue to be cultured in a suboptimal medium. Rizos et al. (2002) found that
modifications to the in vitro culture system can somewhat improve blastocyst quality on both a
morphological and molecular level. For pre-implantation mouse development, it was found that
an optimized in vitro culture system is correlated with an mRNA expression pattern identical to
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in vivo derived embryos (Ho et al., 1995). Therefore, future research needs to be conducted to
improve current embryo culture protocols.
While the majority of the research focusing on in vitro culture conditions in relation to
altered gene expression levels is conducted in pre-implantation embryos, some work focuses on
fetuses post implantation, placental tissues, and neonates or young shortly after birth. Kwong
and colleagues (2000) reported that the Barker hypothesis could be traced as far back as preimplantation development. The Barker hypothesis is fetal adaptations in utero to maternal
undernutrition or malnutrition resulting in specific diseases in the adult (Barker et al., 1993). To
test Barker’s hypothesis and to determine whether early perturbations in metabolism and gene
expression in response to in vitro culture have long term effects exhibited in the resulting
offspring, Ecker et al. (2004) examined the effects of in vitro culture of mouse pre-implantation
embryos to the blastocyst stage on development and behavior of the resulting offspring. This
group found no effect of the culture environment on development to term; however, small but
significant long term alterations in behavior specifically anxiety, locomotor activity, and spatial
memory were observed. Rodents are often apprehensive in both open and elevated areas. The
culture-derived animals, however, spent more time in the open quadrant of a maze used to test
anxiety levels than did the in vivo derived animals. This suggested that alterations in anxiety
were the direct result of artificial embryo culture. Spatial memory was impaired in in vitro culturederived animals when compared with normal mice suggesting that the culture environment
could actually alter brain function, specifically memory storage. They also concluded that the
differences could not be attributed to delays in normal development since there was no variation
in physical, neurological, and behavioral development. Behavior among treatment groups was
also conserved, thus, differences were not due to a few aberrant mice. Mann et al. (2004) tested
the effects of in vitro culture conditions on post implantation embryos/fetuses and placental
tissue. Results indicated a loss of imprinted expression in these later stage embryos and some
placental tissues. These data indicated that the effects of alterations in pre-implantation
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embryos can be seen long after they have been isolated from the culture medium itself.
Therefore, the findings in later stage embryos, placental tissue, and offspring reveal long term
behavioral and developmental consequences of in vitro culture environments. Similar
experiments have not been conducted with human embryos. Due to the increase in assisted
reproductive technologies being applied to humans today, it would be beneficial to determine
what could be accomplished to minimize the effect of the culture environment on the human
pre-implantation embryo.

Genes of Interest
Some of the genes shown to be important to normal mammalian embryonic
development include: oct-4, nanog, connexin 43, and glucose transporter-1 (GLUT-1). Oct-4
and nanog are ICM specific pluripotency factors. ICM cells can be isolated to form embryonic
stem cells that are pluripotent since they are capable of giving rise to all different cell types
found within an organism (Martin, 1981). Thus, oct-4 and nanog are not only important to
embryonic development but also to the field of stem cell research. Connexin 43 is a cell
adhesion factor, and GLUT-1 is a gene important in cellular metabolism.
The POU transcription factor family regulates gene expression via binding to the
octamer sequence ‘ATGCAAAT’ resulting in two domains: a homeodomain distantly related to
the prototype Antennapedia homeodomain and a N-terminal domain designated the POUspecific domain, both required for the activation of transcription (Palmieri et al., 1994). The POU
domain proteins consist of a family of structurally related transcription factors including oct-4.
Most POU proteins play a role in development and cell differentiation as they are expressed
throughout embryogenesis. Oct-4 is a member of Class V of the POU transcription factor family
(Kirchhof et al., 2000). Oct-4 is the earliest known transcription factor to be developmentally
expressed (Chau et al., 2002). Oct-4 is a maternally and zygoticly expressed gene product
found primarily in developing embryos during pre-implantation development and thus regulates
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initial events of development. Zygotic expression does not achieve peak abundance until the 16cell stage, therefore, the maternal oct-4 message diminishes sometime after fertilization and
zygotic expression rises rapidly thereafter. In addition to oct-4 itself, other oct-4-related genes
are found within the early developing embryo (Yeom et al., 1991). Oct-4 is predominantly
localized to the nuclei in all cleavage stages of embryonic development (Palmieri et al., 1994).
Oct-4 is also found in the germ line including primary germ cells of both sexes and in unfertilized
oocytes (Scholer et al., 1989). Oct-4 is expressed at very low levels in the unfertilized oocyte
and is subsequently localized to the female pronuclei upon fertilization (Palmieri et al., 1994).
Unlike in the female gametes, oct-4 is not found in spermatozoa (Scholer et al., 1989). Oct-4 is
a transcription factor that is specifically expressed in pluripotent cells, such as embryonic stem
cells and embryonal carcinoma cells, associating the cells with a state of totipotency (Scholer et
al., 1989; Prusa et al., 2003). When embryonic stem cells are triggered to differentiate, oct-4 is
downregulated (Prusa et al., 2003). Therefore, since oct-4 is expressed in embryonic stem cells,
they are more compatible with early embryonic development allowing for less reprogramming
for NT purposes (Rideout et al., 2000). Oct-4 encodes an early transcription factor that is
required for embryonic mouse development and differentiation past the blastocyst stage (Ovitt
and Scholer, 1998). After gastrulation of the murine embryo around day 8.5 of gestation, oct-4 is
restricted to the germ cell lineage. Oct-4 is silent in somatic cells but active in embryonic cells of
embryos (Boiani et al., 2002). Somatic cells can be induced to express oct-4 via contact with
embryonic blastomeres mediated by signaling through gap junctions (Burnside and Collas,
2002). In the mouse, oct-4 expression begins at the 4-8 cell stage and becomes restricted to the
ICM cells (Palmieri et al., 1994). Yeom and colleagues (1991) stated that oct-4 abundance
appears to coincide with the timing of compaction of the embryo. Oct-4 mRNA in pig and cow
embryos can be detected in both the ICM and the trophectoderm of a blastocyst; however, oct-4
is strictly limited to the ICM in mouse embryos correlating with the undifferentiated cell type,
suggesting that it may be a marker for pluripotency (Kirchhof et al., 2000). Oct-4 is
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downregulated during the formation of the blastocyst and is later restricted to the ICM of
expanded and hatched blastocysts (Palmieri et al., 1994). Oct-4 can be found in bovine preimplantation embryos until day 10 of development (Ponsuksili et al., 2002). In mice, the
restriction of oct-4 to the ICM or primitive endoderm (hypoblast) suggests that oct-4 regulates
both genes involved in determining cell commitment and genes involved in the regulation of
proliferation in specific cell lineages (Palmieri et al., 1994). Subtle changes in oct-4 expression
levels (as small as 30%) have serious consequences for the early post-implantation embryo.
These small changes regulate the differentiation of embryonic stem cells into putative endoderm
or trophectoderm. Increased oct-4 expression triggers differentiation into endoderm or
mesoderm while decreased oct-4 expression triggers dedifferentiation into trophectoderm (Chau
et al., 2002). Bovine IVP blastocysts generally express oct-4 variably. IVP embryos can exhibit
either upregulation or downregulation of the oct-4 gene (Li et al., 2005). This may be in part due
to the variation among embryos in development or due to varying levels of atresia, but the exact
cause is not known (Chau et al., 2002). NT embryos also display marked differences in oct-4
expression when compared to in vivo embryos. A large portion of morula stage clones do not
form blastocysts; thus, oct-4 is an essential marker for pre-implantation development and
beyond. Mammalian clones that do not survive to term tend to either lack oct-4 expression or
the expression is random (Boiani et al., 2002). The abnormalities in oct-4 expression in these
cloned embryos suggest that the state of pluripotency is compromised in many cloned
blastocysts. The reactivation of oct-4 in clones is random and faulty. The abnormal pattern of
oct-4 expression in clones suggests that the developmental competence of the clones is already
compromised at the blastocyst stage to be later reflected in subsequent development (Boiani et
al., 2002). However, Boiani et al. (2003) found that the reduced expression of oct-4 observed in
mice may only be due to a lack in cell number in the cloned embryos. The lack in cell number
could be attributed to apoptotic cell death, a delayed cell cycle progression, or inhibition of cell
proliferation due to metabolic restraints. They found that increasing the cell number in clones by
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aggregation of clones with one another at the 4-cell stage to precede the onset of oct-4
expression dramatically improved expression of oct-4 in blastocysts to levels found in in vivo
embryos. Embryos completely lacking oct-4 generally are lacking ICM cells (Chau et al., 2002),
and thus arrest in development (reviewed by Jaenisch et al., 2004). The failure of this
reactivation may be the cause of embryonic loss seen in NT embryos post- implantation
(reviewed by Jaenisch et al., 2004). Oct-4 acts as a transcription factor in early embryos and its
pattern of expression may be a marker for the extent of nuclear reprogramming that has
occurred in NT embryos. The high degree of sequence similarity, genomic organization, and
chromosomal localization are highly conserved suggesting that oct-4 plays a similar role in all
mammalian species. It has been reported that the murine oct-4 protein shows a widespread
sequence similarity with the bovine protein with a conserved identity of 81.7% (Kirchhof et al.,
2000). It has also been shown that the oct-4 amino acid sequence found in humans is 87%
identical to that of the mouse (Takeda et al., 1992). The high degree of similarities found among
most animals suggests that oct-4 has a universal role among mammalian species.
Nanog is a newly identified transcription factor that contains a homeodomain (like oct-4)
which is specific to maintaining the pluripotency state of embryonic stem, germ, and carcinoma
cells and in pre-implantation embryos in a dose dependent manner (Yamaguchi et al., 2005).
For example, low levels of nanog results in instability in the pluripotency of embryonic stem cells
(Hatano et al., 2005). Nanog has two important characteristics: (1) it has the capacity to
maintain embryonic stem cell self-renewal capabilities independent of other renewal factors, (2)
it is critical for pluripotency status of both the ICM and the trophectoderm. This second
characteristic was confirmed by the deletion of nanog, resulting in the loss of pluripotency in
embryonic stem cells (Li et al., 2005) and the loss of the epiblast in nanog-null murine embryos
(Mitsui et al., 2003). Nanog is generally silent in somatic cells, but can be reactivated during
reprogramming of cells via nuclear transplantation in SCNT (Hatano et al., 2005). Nanog
transcription in stem cells appears to be controlled by the synergistic actions of oct-4 and the
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Sox binding proteins. However, the function of nanog in germ cell development remains largely
unknown. Nanog is detectable in both male and female primary germ cells (Yamaguchi et al.,
2005), and at very low levels in mouse ovaries (Li et al., 2005), but there is no report of the
presence of nanog in the mature germ cells themselves. Degrelle et al. (2005) found nanog to
be expressed in all embryonic and extra-embryonic tissues in later stages of development (1217 days post insemination), but was restricted to the ICM of earlier stage blastocysts. The onset
of nanog embryonic transcription is generally at the 8-cell stage. Therefore, nanog is generally
not detected in very early stage embryos; however, this is not the case when embryonic stem
cells were used as a donor cell for SCNT or in parthenotes. Nanog was found to be expressed
in lower levels of most cloned blastocysts when compared to in vitro blastocysts (Li et al., 2005).
Gap junctions are aggregations of intercellular membrane channels that coordinate
metabolic and electrical activities by controlling the exchange of small metabolites and ions
among adjacent cells (Loewenstein, 1981). These gap junction channels in each cell are
composed of two hemichannels termed connexons. Each connexon is provided by each of the
two communicating cells. Each connexon is subdivided into 6 identical subunits or connexins
(Itahana et al., 1996). The gap junction protein connexin 43 is necessary for the maintenance of
compaction (gap junction formation) and thus, for subsequent blastocyst formation in mice (Lee
et al., 1987). Gap junction formation and communication is essential for growth, cellular
differentiation, and embryonic development (Wrenzycki et al., 1996). Gap junction formation is
also essential for the transport of cryoprotectants and fluids during the cryopreservation and
thawing processes (Rizos et al., 2002, 2003). Connexin 43 is one of the most abundant
connexins and is expressed in numerous tissues including ovaries, placenta, and deciduas in
several species (Wrenzycki et al., 1996). Connexin 43 shares 97% amino acid identity among
mammals (Itahana et al., 1996). Functional gap junctions are first observed during compaction
at the 8-cell stage in murine pre-implantation development, and mRNAs encoding connexin 43
are detected from the 4-cell stage onwards (Wrenzycki et al., 1998), but expression decreases
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slightly thereafter. A peak in connexin 43 expression in mice occurs at the compacted morula
stage and is expressed in both the trophectoderm and ICM at the blastocyst stage (Rizos et al.,
2002). The null (non-lethal) mutant mice for connexin 43 have small gonads in both sexes
because of, at least in part, a deficiency in germ cells traced back to day 11.5 of gestation. From
this finding, Lonergan et al. (2003) concluded that connexin 43 is also required for the earliest
stages of folliculogenesis. During in vitro culture, the cumulus cells of bovine cumulus oocyte
complexes (COCs) are connected to each other via connexin 43 gap junctions; however, these
connections will disappear within 6 to 9 h of in vitro culture (Wrenzycki et al., 1996). The
connexin 43 gene is transcribed only up to the morula stage in IVP bovine embryos whereas the
transcript is present in in vivo derived, cocultured, and ewe oviduct cultured bovine morulae and
blastocysts (Wrenzycki et al., 1996; Rizos et al., 2002, 2003). This result indicates that
connexin 43 could be of both maternal and embryonic origin since the morula stage is just after
the maternal to zygotic transition in vivo. In cattle, the maternal to zygotic transition normally
occurs at the 8- to 16-cell stage in in vivo embryos, whereas in vitro produced embryos tend to
initiate embryonic transcription slightly earlier at the 4-cell stage (Wrenzycki et al., 1996).
McLachlin et al., (1983) found that the gap junctions required for blastocyst formation in mice
could be constructed from precursor pools of connexin 43, and this may be lacking in in vitro
produced embryos. Lonergan et al. (2003) found that the relative transcript abundance of
connexin 43 was significantly increased in the presence of serum compared with when serum
was omitted. Connexin 43 was altered in vitro by the presence of serum, disappearing at the 8to 16-cell stage and reappearing at the hatched blastocyst stage (Lonergan et al., 2003).
However, Wrenzycki et al. (1998) reported that connexin 43 was not affected by the addition of
either serum or BSA, so it is therefore a sensitive candidate gene to be studied as markers for
determining the quality of an in vitro culture system. The difference in expression is probably
due to the extended in vitro culture of these bovine embryos (Wrenzycki et al., 1998). Due to the
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varying differences in connexin 43 observed between IVP and in vivo bovine embryos, this gene
could possibly be a factor for aberrant gene expression in NT embryos as well.
In the mouse, most of the glucose taken up into the system is mediated by facilitative
carriers, otherwise known as glucose transporters (Glut’s) (Gardner and Leese, 1988).
Expression of GLUT-1 is frequently used when testing different culture systems (Wrenzycki et
al., 1999, 2001; Lazzari et al., 2002; de Oliveira et al., 2006). GLUT-1 expression is responsible
for incorporating glucose into embryonic cells throughout the period of pre-implantation
development suggesting that the mRNA is derived from both maternal and embryonic origin
(Lequarre et al., 1997; de Oliveira et al., 2006). Glucose is the critical energy source required
during compaction and blastulation in bovine embryos. GLUT-1 is also expressed in bovine
oocytes aspirated from adult cows (Oropeza et al., 2004). GLUT-1 is distributed in both the
trophectoderm and the inner cell mass in mouse embryos transporting glucose from the
trophectoderm to the ICM, but is predominantly expressed in the bovine trophectoderm
(Wrenzycki et al., 2003). Specifically, GLUT-1 has been shown to increase drastically between
the 8 to 16 cell stage in bovine embryos (Wrenzycki et al., 1998). This upregulation coordinates
with the maternal to zygotic transition and subsequent activation of the embryonic genome. The
morula stage increase in GLUT-1 also indicates that this time period is the point in development
in which the embryos become predominantly dependent on glucose as an energy source
(Wrenzycki et al., 1999). Simply, this is the transition point from the utilization of simple energy
sources such as pyruvate to more complex sources such as glucose or fructose. Hogan and
colleagues (1991) found that GLUT-1 was expressed in a similar pattern in both mouse and
bovine embryos. In addition, both growth hormone (GH) and insulin growth factor 1 (IGF-1)
have been shown to affect GLUT-1 expression in embryos (Orpeza et al., 2004). IGF-1 was
found to have a beneficial effect on the developmental rate of bovine embryos by stimulating the
transport of glucose into the cells during compaction and blastulation. This supports the
hypothesis that the positive effect of IGF-1 is attributed to an enhanced glucose uptake by the
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embryos (Wrenzycki et al., 1998). GLUT-1 expression is altered in bovine in vitro embryos in
response to changes in oxygen concentrations (Lonergan et al., 2006). GLUT-1 may be a
candidate gene for LOS, and could have profound effects on future in vitro culture protocols.
Niemann and Wrenzycki (2000) and Wrenzycki et al. (2001) both found that the relative levels of
the GLUT-1 transcript were higher in in vivo embryos than IVP embryos. This is in agreement
with Morita et al. (1994), who stated that expression of the GLUT-1 gene and glucose uptake
itself are reduced in murine blastocysts produced in vitro when compared to their in vivo
counterparts. Conversely, when either serum or PVA was added to culture media, GLUT-1 was
significantly upregulated in IVP embryos (Wrenzycki et al., 1999). In contrast to other reports, de
Oliveira et al. (2006) did not detect any significant differences among in vivo and IVP embryos
supplemented with different protein sources and serum concentrations. They suggested that is
was not the protein source that was the critical factor contributing to irregular expression of
GLUT-1 between in vitro and in vivo embryos. Therefore, variable results have been found
when analyzing GLUT-1. Due to these contrasting results, GLUT-1 should be further
investigated.
Several genes have been analyzed thus far in connection with abnormal gene
expression in manipulated embryos; however, numerous growth factors could be attributed to
this potential block to normal development. Further research must be done to determine the
exact mechanism(s) responsible for the abnormal development of these fetuses and/or
offspring.

Measuring Gene Expression (mRNA Transcripts)
In Situ Hybridization
Northern blots and microarrays only give an approximate analysis of gene expression at
best. In situ hybridization gives a more detailed report of gene expression by using a labeled
antisense mRNA probe (either DNA or RNA) to hybridize with the mRNA in the sample. The
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labeled probe can be visualized, thus allowing the mRNA sequence of concern to also be
visualized (Gilbert, 2003). However, in situ hybridization can only produce qualitative results
establishing whether or not the gene is being transcribed in the sample, but the level of gene
expression can not be directly determined.
Microarray Analysis
Unlike traditional molecular biology methods that tend to focus only on a single gene at a
particular time, a complementary DNA (cDNA) microarray is an efficient tool for analyzing
thousands of genes in a single experiment to identify potential genes that are critical during a
particular time point or responsible for a certain response (Ushizawa et al., 2004). Microarrays
are commonly used to examine global changes in mRNA abundance across different settings
(Cox et al., 2005). Microarray data can suggest candidate genes for embryonic development
even if they do not have a known function (Ushizawa et al., 2004).
Real-Time Reverse Transcriptase Polymerase Chain Reaction
Quantitative polymerase chain reaction (Q-PCR) is a powerful method to quantify mRNA
levels at very low abundance levels even in single embryos. It is currently the method of choice
in biological studies of gene expression. Several factors have contributed to the transformation
of Q-PCR into mainstream science: (1) since the assay is homogeneous it avoids the need for
post-PCR processing as in traditional reverse transcription PCR (RT-PCR), (2) a wide range
allows straightforward comparisons between RNAs differing in abundance, and (3) the assay is
both quantitative as well as qualitative (Bustin et al., 2005). The transcript of interest can be
measured in a ratio to an endogenous reference gene (or housekeeping gene) to correct for
variation in the quality of RNA preparations, the efficiency of the reverse transcription (RT) and
PCR steps, and in cell number. Thus, Q-PCR measures relative levels of mRNA. Q-PCR is
rapid and robust and the labor to perform the procedure is modest (Bjarnadottir and Jonsson,
2005). A brief review of Reverse Transcriptase PCR (RT-PCR) is necessary to understand how
Real Time RT-PCR (same as Q-PCR) measures the level of gene expression. mRNA is copied
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to cDNA by the reverse transcriptase enzyme. PCR allows the logarithmic copying of small
strands of DNA via a heat tolerant DNA polymerase enzyme. Heat tolerance is important since
RT-PCR is done in cycles thus avoiding the need to add enzyme after the completion of every
cycle. A PCR mix containing a heat-stable polymerase (such as Taq polymerase), specific
primers for the target gene of interest, deoxynucleotides, and a suitable buffer is formulated.
The primers flank the region of DNA to be amplified. It is very important to select primers that
will be optimal for the experimental conditions as to avoid primer-dimer formation, mismatches,
or cross-reactions. It is usually necessary to design, synthesize, and validate several primer
pairs to obtain a set that generates no primer-dimers and results in an amplification efficiency
near 100% (Bustin et al., 2005). The cDNA reaction mix is then heated and cooled allowing the
DNA to denature, primers to anneal and the polymers to extend the product, amplifying the
product after every cycle. A thermocyler is used to precisely control the temperature in each
step. Ethidium bromide (the stain for gel electrophoresis in RT-PCR) is insensitive leading to the
inability to detect small differences between genes. Therefore, SYBR Green, which is generally
used in Q-PCR, will fluoresce brighter than ethidium bromide and is able to detect very small
differences between genes (http://pathmicro.med.sc.edu/pcr/realtime-home.htm).
The basis behind Q-PCR is the more copies of a target gene present at the beginning of
an assay, the fewer cycles of amplification are required to generate the number of amplicons
(the cDNA produced) that can be detected and reach the threshold cycle (Bustin et al., 2005).
The more cDNA of interest (selected for by primers) produced, the more fluorescent will bind
and be detected (http://pathmicro.med.sc.edu/pcr/realtime-home.htm). The fluorescence level is
measured after every Q-PCR cycle and is considered substantial when it crosses a threshold or
background level. The threshold cycle (CT) is defined as the time point in which the sample
fluorescence exceeds an amount above background fluorescence (the time when the threshold
is crossed). The CT is calculated when the individual PCR reaction has synthesized
approximately half of the amplicons. At this point in the reaction, the amount of accumulated
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amplicons is linearly proportional to the amount of target present at the beginning of the assay.
The CT is used for quantifying the amount of the gene of interest yet its value is completely
subjective as the program selects a background value and the threshold can be altered at will
(Bustin et al., 2005). Q-PCR works along the same basis as RT-PCR (some protocols vary in
the reagent used) except the results are different. RT-PCR only gives qualitative results while
Q-PCR gives quantitative results also. Therefore, Q-PCR can not only determine whether or not
the gene is being transcribed in the sample, but it can also determine the level of transcript, thus
measuring the level of gene expression. In particular, in serial dilution samples, it is possible to
determine in which concentration of sample the product disappears. In addition, Q-PCR allows
the comparison of amplicon products against one another via a standard curve. Q-PCR is
advantageous when only a small portion of DNA is available to amplify. RT-PCR requires a
larger starting sample size to enable accurate detection
(http://pathmicro.med.sc.edu/pcr/realtime-home.htm).
Q-PCR utilizes a reference gene to quantify the data. The reference gene will normalize
the RNA levels and justify the observed variations (Wrenzycki et al., 2004). The amount of the
gene of interest is calculated as a ratio to the amount of the reference gene. Selecting the
correct reference gene is critical in properly designing a Q-PCR experiment. Numerous
publications indicate that no one single gene is able to fulfill the criteria required for a universal
reference gene. All genes are regulated to some extent and none are expressed at equal levels
in all cell types irrespective of conditions presented by the experiment. Therefore, it remains up
to the individual researchers to identify and validate the reference gene most appropriate for
their experimental conditions (Bustin et al., 2005). It is very important to prove constant
expression of a reference gene under different experimental conditions or in different tissues;
otherwise data could be misinterpreted or invalid (Bjarnadottir and Jonsson, 2005). Poly (A)
polymerase is often used as a reference gene in many gene expression experiments. The poly
(A) tail is found at the 3’ end of nearly all eukaryotic mRNAs and regulates mRNA breakdown by
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stabilizing the mRNA. Synthesis of the poly (A) tail is carried out by the enzyme poly (A)
polymerase (Lodish et al., 2004). Thus, since the poly(A) tail is found in a ubiquitous manner, so
should the enzyme. This concept makes poly(A) polymerase a valuable reference gene to use
in gene expression analysis.
Because of its sensitivity, Q-PCR is currently the technique of choice to quantify gene
expression. Care must be taken to optimize RNA isolation and PCR conditions prior to
beginning a trial. It is absolutely essential to apply a validation and optimization strategy to
control for the amount of starting material, variation of amplification efficiencies, and differences
between samples in order to allow for reliable results. Nevertheless, this remains the most
intractable problem for Q-PCR quantification (Bustin et al., 2005). If the primers are designed
properly and the procedure is both validated and optimized, the process is relatively simple and
produces accurate results. Q-PCR has replaced some of the older methods of measuring gene
expression simply due to the benefit that Q-PCR lends itself to automation.

Defining Developmental Competence
At lease a portion of IVP and NT blastocysts are developmentally competent because
live offspring have resulted following transfer. SCNT derived morulae and blastocysts can be
produced at a reasonable rate, but development to term of cloned mammalian offspring is
extremely low so far (Boiani et al., 2002). Developmental abnormalities have been reported in
IVP progeny, but are more pronounced and prevalent in embryos derived from NT. The ultimate
test of an embryo is its ability to produce live and healthy offspring post-transfer into a recipient.
Abnormalities of embryos are generally visualized as pregnancy losses or abnormal offspring.
These data points are considered means of testing developmental competence; however, they
are only visualized after transfer or require sacrificing the embryo. There is no specific
“technique” to determine developmental competence of a manipulated embryo prior to transfer
without sacrificing the embryo. In another words, we have no means to detect developmental
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competence in a noninvasive manner. We can only rely on morphological characteristics, such
as the visualization of an inner cell mass (ICM) and a blastocoel cavity at day 7 of in vitro culture
to detect viable embryos. Pronuclear morphology has also been used to detect embryo
developmental competence relying on the fact that zygotes with a normal pronuclear pattern
cleave faster and have a greater chance of developing into blastocysts. However, the high lipid
content of domestic animal embryos hinders the visualization of the pronuclei. Pronuclear
morphological evaluations are limited to the more transparent human or murine zygotes.
Nevertheless in most mammalian species, morphological evaluations with all its drawbacks
remain the method of choice for selecting viable embryos prior to transfer in both cattle and
humans (Lonergan et al., 2006). Generally, studies on the effects of various culture systems
have only focused on the percentage of embryos that cleave and proceed to the blastocyst
stage (Rizos et al., 2003) or hatched blastocyst stage (de Oliveira et al., 2006). Gene
expression studies clearly demonstrate that embryo competence can be severely compromised
without any obvious changes in morphology (Wrenzycki et al., 2004).
The effects of the suboptimal culture environment are mediated through modifications of
the gene expression patterns in the resulting embryos (Tesfaye et al., 2004). Boiani et al. (2002)
indicated that blastocyst formation is usually a good indicator of development preceding
normally, but blastocysts can also be formed in the absence of genes essential for development
including embryos with aberrant imprinting as is the case in parthenotes. Parthenogenesis is
defined as the growth and development of an embryo without fertilization by a sperm cell. The
oocyte is artificially activated and results in development through the pre-implantation period.
Parthenotes generally have reduced cell numbers and an increased proportion of cells within
the ICM (Van De Velde et al., 1999); however, look morphologically identical to normal
embryos. Mammalian parthenotes normally do not survive far beyond the blastocyst stage and
all will fail after implantation (Boiani et al., 2002).
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A clear correlation between the time of first cleavage of the embryo and developmental
competence, including those oocytes that cleave early are more likely to reach the blastocyst
stage than their late cleaving counterparts, has been established (Dinnyes et al., 1999;
Lonergan et al., 1999; Lequarre et al., 2003; Favetta et al., 2004). The end data points in most
studies are limited by analyzing only blastocysts rates and possibly ICM:trophectoderm cell
number ratios as indicators of developmental competence. It is likely that the effects of a given
in vitro culture environment may not visibly manifest themselves during such a short period
(generally 7 days for bovine embryos). Quantitative measurements of gene expression should
give more detailed information on embryo developmental competence (de Oliveira et al., 2006).
Relating expression profiles with noted phenotypic characteristics within definite developmental
stages will elucidate the effect and function of a particular gene or group of genes necessary for
normal development. Eventually, this may enable the establishment of molecular tests for
embryonic developmental capacity (Ponsuksili et al., 2002).
What constitutes a normal embryo? We generally accept in vivo derived embryos as
“normal”. However, not all in vivo embryos collected (generally on day 7) are “normal”. If
embryos are nonsurgically collected from the cow at day 7 and transferred to recipient cows, not
all embryos transferred will make it to term. In fact, pregnancy rates from transferred in vivoderived embryos can range anywhere between ~50% and 75% (Farin et al., 1999). These data
indicate that not all in vivo-derived embryos are viable in early stage embryonic development.
Nevertheless, in vivo embryos are the accepted standard because they are as close to “normal”
as can be obtained.

Comparison to Gene Expression in In Vivo Counterparts
In vivo-derived embryos are considered the “gold standard” to which IVP and NT
produced embryos can be compared with. Studies tend to evaluate NT embryos versus IVP
embryos, since IVP are much more analogous to in vivo embryos. However, no current
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biotechnology application can reiterate the in vivo mechanism. In vitro-derived embryos display
marked differences from their in vivo counterparts (Niemann and Wrenzycki, 2000). When
comparing in vivo derived embryos to those produced in vitro, the embryos produced by artificial
means display marked differences to embryos collected from the animal in gross morphology,
ultrastructure, color, density, number of cells, size, developmental rate, temperature sensitivity,
freezability, viability and pregnancy rates after transfer (Greve et al., 1994). IVP bovine embryos
have darker cytoplasm and lower buoyant density (Pollard and Leibo, 1994), a more fragile
zona pellucida (Rizos et al., 2002), increased proportional volume of cytoplasm (Crosier et al.,
2000), lower pregnancy rates and heavier fetuses after transfer (Hasler, 2001), more
chromosomal abnormalities and a higher lipid accumulation rendering them less tolerant to
cryopreservation (Viuff et al., 1999; Barcelo-Fimbres and Seidel, 2007), and altered gene
expression (Wrenzycki et al., 1996, 1999, 2001; Rizos et al., 2002, 2003). Simply, IVP embryos
are inferior to those derived in vivo. Thus, the in vitro culture effect has a profound effect on the
transcriptional level of the resulting embryo at different stages of development (Lonergan et al.,
2003). Gjorret et al. (2001) reported that apoptosis was more frequently detected in in vitroproduced blastocysts when compared to those derived in vivo. It is hypothesized that this high
incidence of apoptosis is linked to the presence of serum. Differences have been reported
between IVP and in vivo embryos, but also when compared to NT embryos. It is virtually
impossible to copy “Mother Nature”. This inability is not due to the lack of or unavailability of
technology, but rather due to the lack of understanding of the precise and extensive system of
mammalian embryonic development.

A Suitable Model
The outcomes of many experiments conducted using animals not only improve
efficiencies in embryo biotechnologies in animals but also possibly in human infertility treatment.
In humans, the number of patients undergoing assisted reproductive technologies (ART) has
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increased significantly over the past few years. IVP human embryos are now a widely accepted
treatment for unexplained infertility. However, with estimated live-birth rates per cycle varying
between 13% and 28%, its effectiveness has not been rigorously evaluated in comparison with
other ART treatments. A typical human IVF cycle can cost more than $10,000, and insurance
coverage may range anywhere from zero to 100%. Multiple gestations occur in 25% of IVF
human pregnancies and carry an increased risk of premature delivery, low birth weight,
spontaneous abortion, and congenital abnormalities (Harrison and Taylor, 2006). Due to the
effects contributed to the extended culture period in mice or farm animals in terms of aberrant
gene expression, there has been a recent push for a shorter culture environment in the human
ART field. However, the transfer of blastocyst stage embryos increases pregnancy rates and
avoids multiple pregnancies as fewer embryos are needed for transfer per patient (Gardner and
Lane, 1997). Therefore, a prolonged culture is necessary even under potentially deleterious
conditions. Little controlled research has been done on the human embryo, and most of the
experiments have been conducted in the mouse. Most of the information available on
transcription of certain genes in pre-implantation development is derived from studies involving
mice (Wrenzycki et al., 1998). The timing of genomic activation in mice is different from those of
larger mammals. The delay in genomic activation in larger animals may be the consequence of
the lengthened period of pre-implantation development (Kirchhof et al., 2000). As a
consequence, there continues to be growing evidence that the cow is a better model for the
human embryo than the mouse in regards to microtubule patterns during fertilization, closer
timing of genomic activation, intermediate metabolism, and interaction with the culture medium
(Anderiesz et al., 2000; Menezo et al., 2000; Neuber and Powers, 2000; Niemann and
Wrenzycki, 2000; Tesfaye et al., 2004). Furthermore, bovine in vivo embryos are easily
generated and provide a benchmark against which all other embryos can be evaluated
(Wrenzycki et al., 2004).
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Possible Solutions
Consequences of alterations in gene expression levels, epigenetic status, or chromatin
structure may only be visible in the offspring. Understanding how the alternations in gene
expression can be normalized will enhance developmental success and may reduce the long
term affects to the resulting organism (Boiani et al., 2002). Some methods than could increase
the efficiency of NT fetuses and offspring include: aggregation of embryos to normalize gene
expression as was done with oct-4 (Boiani et al., 2003), addition of methyl groups to cytosine
residues of the NT embryo’s DNA, and as hypothesized by our laboratory defining a more
optimal culture environment for manipulated embryos. Improving the culture of embryos during
the pre-implantation period can contribute to the production of qualitatively superior embryos for
transfer resulting in an increased efficiency and healthier offspring.
Various technologies such as artificial insemination, embryo transfer (mostly in bovine),
and cloning have been applied to mammalian reproduction. The effects of the short term in vitro
culture environment raise questions about long term consequences and the safety of ART
(Lonergan et al., 2006). A precise knowledge of the control of gene expression during the entire
pre-implantation period is necessary to improve these technologies (Ushizawa et al., 2004).
Detailed analyses of gene expression profiles during bovine embryogenesis will be a valuable
tool to better understand basic cellular and molecular mechanisms that control very early
development, thus allowing for the refinement of culture systems and better strategies for
transgenic and cloning studies. Analysis of differences in mRNA expression could possibly allow
the opportunity to alter gene expression by modifying the culture environment thus improving
post-thaw viability of IVP embryos (Rizos et al., 2003). SCNT will also continue to play a role in
biotechnology. Therefore, many of the factors controlling transcription and gene expression of
these NT fetuses and offspring remain to be studied and therefore understood.
Some cloned offspring have been successful. As a result, it is imperative to evaluate
why only a small percentage of NT embryos develop into healthy offspring. We believe it would
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be beneficial to try to compose a list of developmentally important genes that could better
determine developmental competence of manipulated embryos prior to transfer. By analyzing
this potential list of genes on a select few embryos from a donor or IVP/NT pool, one could
better predict the viability of the embryo once transferred into a recipient. In may be possible in
the future to even determine developmental competence by either taking a biopsy or bisection
of an embryo to analyze the potential list of candidate genes (Li et al., 2005). Combining
traditional measurements of developmental competence (cleavage and blastocyst rates) with
qualitative measures, such as PCR should give a more complex picture of the consequences of
modifying a culture environment on the embryo (Rizos et al., 2003). Therefore, our goal was to
increase the efficiency of embryo biotechnologies through a better understanding of the
transcriptional mechanisms controlling gene expression. Specifically, the objective of this thesis
research is to determine if alterations to current in vitro culture conditions will affect gene
expression and/or make embryo biotechnologies more efficient.
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CHAPTER III
EFFECTS OF CULTURE MEDIUM AND PROTEIN SUPPLEMENTATION ON mRNA
EXPRESSION OF IN VITRO PRODUCED PREIMPLANTATION BOVINE EMBRYOS
Introduction
In vitro production (IVP) of bovine embryos has become a reliable alternative to
conventional superovulation induction techniques and has been used as a tool to study preimplantation embryo development (reviewed by Bavister, 1995). In particular, the 5-6 day post
fertilization period of IVP embryos is the time when various developmentally important events
occur including the first cleavage division which is critical in determining the subsequent
development of the embryo (Lonergan et al., 1999), activation of the embryonic genome (Memili
and First, 2000) also known as the maternal to zygotic transition, compaction of the morula,
which involves the establishment of the first cell-to-cell contacts within the embryo, and
blastocyst formation, which is the time point of the first differentiation into two cell types the
trophectoderm and the inner cell mass (ICM). This time period is generally referred to as the
pre-implantation period. This period is characterized by distinct morphological steps that must
include a well-orchestrated expression of genes derived from both the maternal and embryonic
genomes to allow for compaction, cavitation, and blastocoel expansion (Kidder, 1992).
IVP is more efficient in terms of producing live offspring than is nuclear transfer (NT), but
substantial losses have been noted (reviewed by Farin et al., 2006). Most of the losses in IVP
seem to be during the in vitro culture stages (between the 2-cell and blastocyst stages)
suggesting that the post-fertilization environment is the most critical period of development in
terms of determining blastocyst yield (Lonergan et al., 2006). The relative abundance of
numerous transcripts varies through the early pre-implantation period and is strongly influenced
by the culture environment (Wrenzycki et al., 1996, 1999, 2001, 2004; Eckert and Niemann,
1998; Lazzari et al., 2002; Rizos et al., 2002, 2003; Lonergan et al., 2003). Current culture
systems can also lead to either persistent silencing or enhanced expression of a particular gene
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throughout the critical phases of fetal development (Wrenzycki et al., 2001). Therefore, any
modifications to the in vitro culture environment can have profound effects on the quality of the
resulting embryos measured in terms of cryotolerance, relative transcript abundance (Lonergan
et al., 2003), and development to term. The culture environment is a common aspect of both
IVP and NT; consequently, research focusing on the in vitro culture system will not only better
IVP but NT also. However, little effort is often given to what implications could arise from using
these artificial technologies in terms of its effects on gene expression.
It is evident that pre-implantation embryos are able to develop in vitro in a wide array of
culture conditions. They are able to develop in media ranging in composition from simple
balanced salt solutions to complex systems supplemented with serum and somatic cells
(Lonergan et al., 2006). However, this ability to adapt to the environment, especially under
suboptimal or even nonphysiological conditions, comes at a cost to the embryo in terms of
embryo quality (Rizos et al., 2002). Blastocysts produced following culture in synthetic oviductal
fluid [SOF (Tervit et al., 1972)], a medium designed for pre-implantation embryos, have
significantly altered patterns of genes involved in gap junction formation, apoptosis, oxidative
stress and differentiation compared to their in vivo counterparts (Rizos et al., 2002). Ho et al.
(1995) reported that in the mouse, the potassium simplex optimized medium [KSOM (Lawitts
and Biggers, 1991a, b)] supplemented with amino acids or serum provided very similar
expression profiles (almost identical) as those found in in vivo embryos.
Most commonly used culture media are supplemented with either calf serum (CS) or
bovine serum albumin (BSA) as a protein source. Different protein sources in culture media can
greatly influence development of IVP embryos, ranging from either a marked stimulation in
some aspects to a significant inhibition of other processes. In fact, the quality of serum and BSA
can vary greatly depending on the source and specifically for serum, the lot number (Bavister,
1995). Serum has been shown to have a biphasic influence on the developmental capacity of
bovine embryos by inhibiting the first cleavage division but enhancing later blastocyst
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development (Wrenzycki et al., 1998). Serum can rate the speed of embryo development and
the resulting quality of the embryos produced (Rizos et al., 2003). Serum supplementation has
also been linked to a high incidence of apoptosis in IVP blastocysts (Gjorret et al., 2001).
However, Barcelo-Fimbres and Seidel (2007) reported that a serum free culture yielded a
blastocyst rate not significantly different from the blastocyst rate achieved with serum
supplementation. The presence of serum over a prolonged period of time has been shown to
alter the expression pattern of various genes (Wrenzycki et al., 1999). Lonergan et al. (2003)
reported that simply omitting serum from the culture medium during the post-fertilization period
changed mRNA abundance for several developmentally important genes.
Embryonic anomalies are generally visualized as pregnancy losses or abnormal
offspring. There is no specific “technique” to determine developmental competence of an
embryo prior to transfer without sacrificing the embryo. We can only rely on morphological
characteristics such as the visualization of an ICM and a blastocoel cavity at day 7 of in vitro
culture to detect viable embryos. Boiani et al. (2002) indicated that blastocyst formation is
usually a good indicator of development preceding normally, but blastocysts can also be formed
in the absence of genes essential for development including embryos with aberrant imprinting
as is the case in parthenotes. Gene expression studies clearly demonstrate that embryo
competence can be severely compromised without any obvious changes in morphology
(Wrenzycki et al., 2004). It is likely that the effects of a given in vitro culture environment may
not visibly manifest themselves during such a short period (generally 7 days for bovine
embryos). Quantitative measurements of gene expression should give more detailed
information on embryo developmental competence (de Oliveira et al., 2006). Specifically, we
believe that PCR analysis of suitable candidate genes for developmental competence would be
a valuable tool to test a select group of embryos prior to transfer.
Some of the genes shown to be important to normal mammalian embryonic
development include: oct-4, nanog, connexin 43, and glucose transporter-1 (GLUT-1). Oct-4 is
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the earliest known transcription factor to be developmentally expressed (Chau et al., 2002) and
thus regulates initial events of development. Oct-4 mRNA in pig and cow embryos can be
detected in both the ICM and the trophectoderm of a blastocyst; however, oct-4 is strictly limited
to the ICM in mouse embryos (Kirchhof et al., 2000). Nanog is a newly identified transcription
factor that contains a homeodomain (like oct-4) which is specific to maintaining the pluripotency
state of embryonic stem, germ, and carcinoma cells and in pre-implantation embryos in a dose
dependent manner (Yamaguchi et al., 2005). The gap junction protein connexin 43 is necessary
for the maintenance of compaction (gap junction formation) and thus, for subsequent blastocyst
formation in mice (Lee et al., 1987). Gap junction formation and communication is essential for
growth, cellular differentiation, and embryonic development (Wrenzycki et al., 1996). Expression
of GLUT-1 is frequently measured when comparing different culture systems (Wrenzycki et al.,
1999, 2001; Lazzari et al., 2002; de Oliveira et al., 2006). GLUT-1 is responsible for
incorporating glucose into embryonic cells throughout the period of pre-implantation
development (Lequarre et al., 1997; de Oliveira et al., 2006). GLUT-1 is expressed in both the
trophectoderm and the inner cell mass in mouse embryos transporting glucose from the
trophectoderm to the ICM, but is predominantly expressed in the trophectoderm of bovine
embryos (Wrenzycki et al., 2003).
Since the culture environment itself may alter gene expression levels of various
developmentally important genes, this study examined the development potential of in vitro
produced bovine embryos cultured in two commonly used culture systems, SOF or KSOM
supplemented with amino acids (SOFaa or KSOMaa, respectively) to determine if differences in
media composition would effect gene expression levels. A second experiment assessing the
same two media with or without CS (BSA supplemented) was also conducted to determine if the
protein source utilized would affect gene expression levels. Additionally, we investigated the
expression of oct-4, nanog, connexin 43, and GLUT-1 in IVP and in vivo embryos on day 7 of
pre-implantation development.
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Materials and Methods
Experimental Design
Experiment 1
Ten pools of in vitro produced blastocysts (10 embryos per pool) were generated for
each treatment. In vivo embryos were obtained by nonsurgical embryo collection on day 7 from
mature cows and allotted into pools of 10 (10 pools, n=10). IVP embryos were synthesized as
follows. IVF was performed and embryos were cultured according to treatment in either SOFaa
or KSOMaa. Blastocysts were recovered after 7 days of culture (either in vivo or in vitro) and
morphology was recorded. RNA was isolated, reverse transcribed to cDNA, and gene-specific
amplified via Quantitative (Real-Time) PCR (Q-PCR).
Experiment 2
Eleven pools of in vitro produced blastocysts (5 embryos per pool) were generated for
each treatment. As in Experiment 1, transcriptional expression levels were compared with the
levels present in vivo embryos.
In vivo embryos were obtained as in Experiment 1 and were allotted into pools of 10 (10
pools, n=10). IVP embryos were synthesized as in Experiment 1 with the exception of the
culture environment. Embryos were cultured according to treatment in either SOFaa, SOFaa
with CS, KSOMaa, or KSOM with CS medium (4 treatments total). Blastocysts were recovered
after 7 days of culture (either in vivo or in vitro) and morphology was recorded. RNA was again
isolated, reverse transcribed to cDNA, and gene-specific amplified via Q-PCR.
In Vitro Production of Embryos
Cumulus oocyte complexes (COCs) were obtained from a commercial supplier (Conco
Valley Genetics, TX, USA; Bomed, Inc., WI, USA). COCs arrived in vials containing in vitro
maturation (IVM) medium (TCM-199, 10% fetal bovine serum (FBS), 0.1% Penicillin/
Streptomycin (P/S), Na pyruvate, L-glutamine, 50 ng/ml of epidermal growth factor, FSH, LH,
and E2) held at 39°C, and stabilized with CO2. At 22 h post-maturation COCs were subjected to
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in vitro fertilization (IVF). Briefly, COCs were aspirated from the IVM vials and washed twice in
HEPES-TALP (Tyrodes’s, albumin, lactate, pyruvate) containing 114 mM NaCl, 3.2 mM KCl, 2
mM NaHCO3, 0.34 mM NaH2PO4, 10 mM HEPES, 10 mM lactic acid, 2 mM CaCl2·2H2O, 0.5
mM MgCl2·6H2O, 0.2 mM Na pyruvate, 3 mg/ml of Fraction V BSA, 1% P/S, and 5 μg/ml of
phenol red.
COCs were inseminated for 17 to 18 h in 50 μl droplets of IVF medium under mineral oil
at 39°C in a humidified atmosphere using frozen-thawed semen from one Holstein bull with a
history of proven fertility in our IVF program (post-thaw motility as high as 90-95%). After semen
was thawed for 30 sec in a 37°C water bath, motile spermatozoa were separated using a
Percoll discontinuous gradient by centrifugation for 20 min at 750 X g. Motile spermatozoa were
also washed in Sperm-TALP containing 100 mM NaCl, 3.1 mM KCl, 25 mM NaHCO3, 0.29 mM
NaH2PO4, 10 mM HEPES, 21.6 mM lactic acid, 2.1 mM CaCl2·2H2O, 1.5 mM MgCl2·6H2O ,
1mM Na pyruvate, 6 mg/ml of Fraction V BSA, 1% P/S, and 5 μg/ml of phenol red by
centrifugation for an additional 10 min at 400 X g to remove any excess cryoprotectant. A sperm
concentration of 1 X 106 motile sperm per ml was used for IVF based on hemacytometer counts.
The IVF medium consisted of IVF-TALP (114 mM NaCl, 3.2 mM KCl, 25 mM NaHCO3, 0.34 mM
NaH2PO4, 10 mM lactic acid, 2 mM CaCl2·2H2O, 0.5 mM MgCl2·6H2O, 0.2 mM Na pyruvate, 6
mg/ml of essentially fatty acid free BSA, 1% P/S, and 5 μg/ml of phenol red) supplemented with
1 mM epinephrine, 10 μM hypotaurine, 20 μM penicillamine, and 2 μg/ml of heparin. After IVF,
the presumptive zygotes with cumulus cells were denuded in a hyaluronidase solution (1 mg/ml)
via vortexing for 2 min. To ensure that the transcripts analyzed did not originate from residual
cumulus cells, “cumulus-free” zygotes were washed twice in HEPES-TALP prior to initiating
culture. Presumptive zygotes were cultured in 30 μl drops of the appropriate culture medium
held at 39°C under embryo-tested, sterile-filtered mineral oil (Sigma-Aldrich, Inc., St. Louis, MO,
USA) in a 5% CO2, 5% O2, and 90% N2 humidified atmosphere up to 8 days. On day 3, all
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embryos were transferred to fresh medium and cleavage rate was determined. In Experiment 2,
half the embryos per culture treatment (SOFaa or KSOMaa) were transferred to fresh medium
containing 5% calf serum on day 3 of culture. Embryos reaching the blastocyst stage by day 7
were used for gene expression analysis or cell counting. Embryos not reaching the blastocyst
stage until day 8 were used as a separate treatment for cell counting.
Culture Media
KSOM medium (Lawitts and Biggers, 1991a, b) consisted of 95 mM NaCl, 2.5 mM KCL,
0.35 mM KH2PO4, 0.20 mM MgSO4·7H20, 20.49 mM DL-lactic acid, 0.20 mM D-glucose, 25 mM
NaHCO3, 0.20 mM pyruvic acid, and 5 μg/ml of phenol red. KSOMaa was supplemented with 1
mM L-glutamine, essential amino acids (50X Basal Medium Eagle [BME]), non-essential amino
acids (100X Minimum Essential Media (MEM)), 3 mg/ml of Fraction V BSA, and 1% P/S. SOF
medium (Tervit et al., 1972) consisted of 107.7 mM NaCl, 7.16 mM KCl, 1.19 mM KH2PO4,
25.07 mM NaHCO3, 3.3 mM DL-lactic acid, 0.49 mM MgCl2·6H2O, 1.71 mM CaCl2·2H2O, and 5
μg/ml of phenol red. SOFaa was supplemented with 1 mM L-glutamine, 0.33 mM Na pyruvate,
1.5 mM D-glucose, 50X BME, 100X MEM, 3 mg/ml of Fraction V BSA, and 1% P/S. In
Experiment 2, half the embryos per culture medium were supplemented with 5% CS on day 3 of
in vitro culture. All culture conditions were stabilized by embryo-tested, sterile-filtered mineral oil
and held at 39°C in a 5% CO2, 5% O2, and 90% N2 humidified atmosphere.
Collection of In Vivo Embryos
Crossbred beef cows were synchronized and superovulation was induced using a
standard protocol. Briefly, estrus synchronization was achieved by insertion of an Eazi-Breed
CIDR™ (Controlled Intravaginal Releasing Device; Pharmacia & Upjohn Company, Kalamazoo,
MI, USA) containing 1.38 g of progesterone. An injection of 15 mg progesterone and 2.5 mg
estradiol-17β was given at CIDR insertion (day 0). Stimulation was achieved by twice daily (A.M.
and P.M.) Follitropin V (Bioniche Animal Health, Canada) FSH injections on days 4, 5, and 6 of
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the treatment. On day 6 (P.M.), the CIDR was removed and 5 ml of Lutalyse (5 mg/ml) was
given. On day 7, a final FSH injection was given in the morning. The total FSH dose per donor
was 236 mg. Donors exhibiting estrus behavior were artificially inseminated at 12 and 24 h after
the onset of standing estrus. Estradiol was given on the morning of artificial insemination,
followed by a nonsurgical embryo collection 7 days later. Collected embryos were held in a
commercial embryo holding medium (Holding Plus®, BIONICHE, Pullman, WA, USA) for a
period of 1 to 2 h at 37°C until long term storage at -80°C for further gene expression analysis.
Differential Staining
Day 7 and day 8 blastocysts were incubated in dPBS containing 1 mg/ml of Hoechst
33342 for 10 min. Trophectoderm cells were permeabilized with 0.4% Triton X-100 for 1 min
and counterstained with 25 mg/ml of propidium iodide (PI) for 45 sec. Stained embryos were
mounted onto a glass microscope slide in a drop of 25% glycerol. Embryos were gently
flattened with a coverslip and visualized for cell counting. The number of trophoblast (nucleus
stained with PI) and inner cell mass (ICM, nucleus stained with Hoechst 33342) cells was
determined using an epiflourescent microscope equipped with a UV filter cube.
Isolation of mRNA
mRNA (or poly(A)+ RNA) was isolated from pools of bovine blastocysts (in vitro and in
vivo) using the Dynabeads® mRNA Direct™ Micro Kit (Dynal Biotech, Inc., Lake Success, NY,
USA) within a PCR isolation hood. The protocol used is described by Wrenzycki et al. (1998)
and consists of the manufacturer’s instructions with minor modifications. Briefly, pools of
embryos were first stored at -80°C in approximately 3 μl of PBS plus 0.1% polyvinyl alcohol
(PVA) in 1.5 ml siliconized tubes. Embryo pools were lysed in 150 μl lysis/binding buffer (100
mM Tris HCl (pH 8.0), 500 mM LiCl, 10 mM EDTA, 1% lithium dodecylsulfate, and 5 mM
dithiothreitol) followed by a 10 sec vortex to ensure complete lysis. Samples were centrifuged at
12,000 g for 15 sec and incubated for 10 min at room temperature. Pre-washed Dynabeads®
(10 μl) were combined with the sample solute. The sample poly(A)+ RNAs were allowed to
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anneal to the beads (dT25) while rotating on a hybridization mixer for 10 min. The beads were
separated from the mix using a Dynal MPC-E-1 magnetic separator. The sample was washed
once in 100 μl wash buffer A (10 mM Tris HCl (pH 8.0), 150 mM LiCl, 1 mM EDTA, and 0.1%
lithium dodecylsulfate) and three times in 100 μl wash buffer B (10 mM Tris HCl (pH 8.0), 150
mM LiCl, and 1 mM EDTA). The mRNA was then eluted from the beads in 11 μl sterile water
heated at 75°C for 2 min and was used immediately for reverse transcription.
Reverse Transcription
mRNA isolated from different pools of embryos or fibroblast cells (used as an internal
calibrator) was reverse transcribed into cDNA in a total volume of 20 µl using both oligo (dT)
and random hexamer primers to enable reverse transcription of a wide variety of targets <1kb in
length. Reverse transcription was performed using the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). The 20 μl iScript RT Reaction Mix consisted of: 4 μl of
iScript reaction mix, 1 μl of reverse transcriptase, 4 μl of nuclease-free water, and 11 µl of
sample mRNA. A reaction mix was formulated for the sample and for a no template negative
control. The reaction was conducted at 25°C for 5 min, 42°C for 30 min, a denaturation step of
85°C for 5 min, and a final holding temperature of 4°C.
Validation and Optimization of Q-PCR
Reference genes that have been used in other gene expression experiments include:
poly(A) polymerase (Wrenzycki et al., 1998), Histone H2a and glucose 6-phosphate
dehydrogenase (Lonergan et al., 2003). All three primer sets for the reference genes were
validated first using fibroblasts and then with embryos using RT-PCR and gel electrophoresis.
From these results, poly(A) polymerase was chosen as the reference gene due to its ability to
produce more consistent results as compared with the other two primer sets.
PCR products for each gene of interest were also obtained via RT-PCR and were
electrophoresed on an agarose gel. Each amplicon was sequenced to confirm the amplification
of the proper product. To assure that the primer sets did not amplify genomic DNA, 1 ng of
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genomic DNA was used as a template for the amplification of the target genes. No amplicons
were recovered after RT-PCR of genomic DNA (data not shown).
An annealing temperature gradient and primer concentration matrix were performed for
each target gene to determine the optimal annealing temperature and primer concentration
(both sense and antisense primers) to ensure maximum amplification. To ensure that the
primers amplified a single product in a quantitative manner, amplification efficiency and a
correlation coefficient from a standard curve of cDNA at four different 10-fold dilutions were
determined for each gene utilizing Q-PCR (Figure 3.1). All of the target genes had acceptable
efficiencies (80 to 120%) and correlation coefficients (close to 1.0).
For optimization purposes, fibroblast cDNA was used in optimizing poly(A) and connexin
43. For optimization of oct-4 and nanog, plasmids containing the PCR amplicons were
constructed using the pCR-XL-TOPO Cloning® Kit (Invitrogen Corporation, Carlsbad, CA,
USA). All Q-PCR for optimization purposes was performed following the same RT and Q-PCR
protocols discussed elsewhere with the exception of the mRNA isolation from the fibroblasts.
Briefly, mRNA was isolated using the same protocol discussed above with alternative volumes.
Fibroblast cells were lysed in 1250 μl lysis buffer. The sample was sheared with a 21 g needle 3
to 5 times using a 1 to 2 ml syringe to ensure complete lysis and vortexed for 10 sec. Prewashed Dynabeads® (250 μl) were combined with the sample solute. As before, the sample
poly(A) tails were allowed to anneal to the beads (dT25) while rotating on a hybridization mixer
for 10 min. The beads were washed twice in 1 ml of wash buffer A and three times in 1 ml of
wash buffer B. The mRNA was eluted from the beads as before.
Q-PCR
PCR primers were designed to amplify poly(A) polymerase, oct-4, nanog, connexin 43,
and GLUT-1 from the coding regions in bovine gene sequences using the Beacon Designer 4.0
(PREMIER Biosoft International) (Table 3.1). cDNA from 2 embryo equivalents for the first
experiment and 1 embryo equivalent for the second experiment were amplified for each gene
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A

B

C

Figure 3.1. Dilution Ct values, melting curves, and standard curve obtained using primers for the
amplification of connexin 43. Four 10-fold dilutions (100,000, 10,000, 1,000, and 100 cells) were
used to generate dilution curves (A), melting curve data (B), and standard curve (C).
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Table 3.1 Primers used for Q-PCR analysis.

Gene

Accession
Number

Poly(A)

X63436

Sense AAGCAACTCCATCAACTACTG
Antisense ACGGACTGGTCTTCATAGC

169

Oct-4

NM_174580

Sense CCACCAGCAGGCAAACAC
Antisense GAGAAGGCGAAGTCAGAAGC

223

Nanog

DQ069776

Sense AATTCCCAGCAGCAAATCAC
Antisense CCCTTCCCTCAAATTGACAC

215

Connexin 43

BC105464

Sense CGTGTCATTGGTGTCTCTTG
Antisense AATTCTGGTGGTCGTCTGG

386

GLUT-1

M60448

Sense TGGGAAAGTCCTTTGAGATG
Antisense TCGTTGCGGTTAATGAGC

316

Primers
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Amplicon
Length (bp)

using the iQ™SYBR Green Supermix in the MyiQ Reverse Transcription PCR Detection
System (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The Q-PCR Reaction Mix
consisted of 12.5 μl of iQ SYBR™ Green 2X Supermix, 4 μl of cDNA or H2O, 6.5 μl of
nuclease-free water, and 1 μl of each primer (sense and antisense at 20 pmol
concentrations). For each sample (embryo pool), reactions were performed for the
reference gene, each gene of interest, and a no template negative control. Within each
Q-PCR assay or plate setup, reactions for the reference gene and each gene of interest
were performed using the calibrator cDNA. The calibrator consisted of a mixture of
cDNA from fibroblasts, plasmids, and embryos. The PCR program used for the
amplification of all genes consisted of a denaturing cycle of 3 min at 95°C; 40 cycles of
PCR (95°C for 10 sec and 55°C for 45 sec); a melting curve analysis which consisted of
95°C for 1 min followed by 55°C for 1 min, a step cycle with 80 repeats starting at 55°C
for 10 sec with a +0.5°C/sec transition rate; and a final holding temperature of 4°C.
Data was quantified using the method for relative quantification in Q-PCR
described by Pfaffl (2001).Values are reported as relative transcription or the n-fold
difference relative to a calibrator. A mixture of cDNA from fibroblast cells, plasmids, and
embryos was used as a calibrator for all of the target genes. poly(A) polymerase was
used as the internal reference gene. The threshold cycle (CT) value of the reference
gene was used to normalize the target gene signals in each sample. The amount of
target transcripts relative to the calibrator was calculated using the following equation:
n-fold difference = Efficiency Target GeneΔCTT/ Efficiency Reference GeneΔCTR. The
ΔCTT (for the target gene) value was calculated by subtracting the sample CT value of
the target gene from the calibrator CT value of the target gene. The ΔCTR (for the
reference gene) value was calculated by subtracting the sample CT value of the
reference gene [poly(A)] from the calibrator CT value of the reference gene. Therefore,
all target abundance levels were expressed as n-fold differences relative to a calibrator
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and normalized to the reference gene in order to compensate for PCR variations
between runs.
Statistical Analysis
Data were analyzed using SigmaStat Statistical Software Version 3.5 (Systat
Software, Richmond, CA, USA). Cleavage and blastocyst rates between treatment
groups were analyzed using Chi-Square analysis. ICM cell number, trophectoderm cell
number, total cell number, ICM:Trophectoderm ratio, and gene expression levels were
tested for normality and equal variance using Kolmogorov-Smirnov and Levene’s
Median test, respectively. One-way ANOVA, followed by multiple pair-wise comparisons
using Tukey’s test when applicable, was used to detect differences in abundance levels
between treatments and in vivo embryos. One-way ANOVA was also used to detect
differences in ICM cell number, trophectoderm cell number, total cell number, and cell
ratio of treatment embryos when compared to in vivo counterparts and treatment
embryos produced after different times in culture. Differences of P≤0.05 were considered
to be significant.
A 95% confidence interval for the gene expression levels of in vivo embryos for
each gene of interest was formulated using descriptive statistics. If the n-fold difference
relative to the calibrator for each treatment embryo equivalent did not fall within the
confidence interval for the in vivo embryos, they were considered abnormal, either
upregulated or downregulated.
It should be noted that different commercial oocyte suppliers were used in each
of the experiments. As a consequence, no comparisons were made between
experiments and embryos were produced at separate times for each experiment.
Additionally, in Experiment 2, SOF treatment (SOFaa and SOFaa with CS) embryos
were generated from separate pools of oocytes than KSOM treatment (KSOMaa and
KSOMaa with CS) embryos. Therefore, to ensure that differences were attributed to the
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treatment itself and not variation between oocyte pools, all comparisons were only made
between the two related treatment groups (SOFaa or KSOMaa with and without CS) and
in vivo embryos for the second experiment.

Results
Experiment 1: Effect of Media Composition on Gene Expression Levels
Embryo Development and Cell Number
KSOMaa embryos produced did not differ in cleavage rate or in the number of 8
to 16-cell embryos present 72 h post-insemination (hpi) when compared with SOFaa
embryo production rates. The percentage of blastocysts, calculated from the total
number of cleaved embryos, was also not significantly different among the two
treatments (Table 3.2).
The mean total cell number and mean trophectoderm cell number in blastocysts
at day 7 cultured in either KSOMaa or SOFaa (143 ± 9.2 and 99 ± 7.7 versus 156 ± 9.5
and 117 ± 8.2, respectively) was significantly higher than the mean total cell number and
mean trophectoderm cell number of day 7 in vivo embryos (100.8 ± 11.9 and 69.3 ± 8.6,
respectively). Additionally, the mean ICM cell number in day 7 in vivo embryos (32 ± 3.4)
was significantly lower than the KSOMaa cultured blastocysts (44 ± 2.8), and the
ICM:TE ratio was significantly greater in day 7 SOFaa cultured blastocysts (1:3.0 ± 0.3)
when compared to both KSOMaa cultured blastocysts (1:2.3 ± 0.2) and in vivo
blastocysts (1:2.2 ± 0.1) (Table 3.3). Mean cell number data for day 7 blastocysts was
also compared with data collected from day 8 blastocysts (Table 3.4). Significant
differences for mean ICM number, trophectoderm number, and total cell number were
detected among day 7 and day 8 IVP blastocysts. No significant difference in ICM:TE
ratio was detected among day 7 and day 8 IVP blastocysts (Figure 3.2).
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Table 3.2 Embryonic development of IVP embryos cultured in either KSOMaa or SOFaa.
Blastocysts† (%)
Clvd
8-16 cell*
Treatment
n
From Clvd
From 8-16 cell
(%)
(%)
KSOMaa

909

675 (74)

174 (19)

125 (19)

125 (72)

SOFaa

932

611 (74)

158 (17)

119 (20)

119 (75)

*8-16 cell embryos 72 h post-insemination
†
Total blastocysts at day 8.
No significant differences between treatments.
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Table 3.3 Cell number of blastocysts after 7 days of in vivo or in vitro culture in either KSOMaa
or SOFaa.
Treatment

n

ICM

TE*

ICM:TE

KSOMaa

14

44 ± 2.8a

99 ± 7.7a

1:2.3 ± 0.2a

143 ± 9.2a

SOFaa

17

42 ± 3.0a,b

117 ± 8.2a

1:3.0 ± 0.3b

156 ± 9.5a

In Vivo

10

32 ± 3.4b

69.3 ± 8.6b

1:2.2 ± 0.1a

100.8 ± 11.9b

*TE = Trophectoderm
Data presented as mean ± SEM.
Statistical differences were determined by One-Way ANOVA (P<0.05).
a,b
Different letters within columns indicate significant difference between treatments.
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Total Cells

Table 3.4 Cell number of IVP blastocysts after 8 days of culture in either KSOMaa or SOFaa.
Treatment

n

ICM

TE*

KSOMaa

21

28 ± 2.7

59 ± 4.0

1:2.7 ± 0.4

86 ± 5.8

SOFaa

16

24 ± 2.9

53 ± 5.8

1:2.5 ± 0.3

77 ± 8.0

*TE = Trophectoderm
Data presented as mean ± SEM.
Statistical differences were determined by t-test (P<0.05).
No significant differences between treatments.
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ICM:TE

Total Cells

A

d7
d8

B
50

140

a,1

a,1

a,1,2

40

a,1

Mean TE Number

Mean ICM Number

120
2
b,1

30

b,1

20
10

100
80

2
b,1

60

b,1

40
20
0

0
In Vivo

KSOMaa

In Vivo

SOFaa

KSOMaa

SOFaa

Treatment

Treatment

C

D
3.5
1

a,1

160
1

1

Mean Total Cells

Mean ICM:TE Ratio

3.0
2.5

180

2

1

2.0
1.5
1.0

a,1

140
120

2

100

b,1

b,1

80
60
40

0.5

20

0.0

0
In Vivo

KSOMaa

In Vivo

SOFaa

KSOMaa

SOFaa

Treatment

Treatment

Figure 3.2 Differential staining cell numbers for in vivo embryos compared to IVP
blastocysts cultured for 7 days (dark gray bars) and 8 days (light gray bars). Mean ICM
cell number (A), mean trophectoderm (TE) cells (B), mean ICM:TE ratio (C), and mean
total cell number (D). Bars indicate SEM. Statistical differences were determined by
One-Way ANOVA (P<0.05).
a,b

Significant differences within treatments between days.
Significant differences between treatments within days.

1,2

*Mean values are given as 1:TE cell ratio.
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Transcription Levels in Pre-implantation Embryos
Oct-4 transcript levels in blastocysts cultured in KSOMaa were significantly
different from both blastocysts cultured in SOFaa and day 7 in vivo embryos. Connexin
43 transcript levels were below detectable levels in KSOMaa, SOFaa, and in vivo
cultured embryos. In addition, the mRNA expression levels for nanog and GLUT-1 were
not significantly different among treatment groups (Figure 3.3).
Mean relative levels may not be the best method of analysis of gene expression
data in particular when using smaller sample sizes (number of embryo pools). Therefore,
confidence levels for in vivo embryos were calculated to better interpret the data. A high
proportion of IVP blastocysts cultured in KSOMaa displayed abnormal levels of nanog.
Only 40% of KSOMaa cultured blastocysts had normal expression levels of nanog,
whereas, 63% of SOFaa blastocysts had normal transcript levels on day 7. Irrespective
of the treatment, the majority of the IVP blastocysts analyzed for GLUT-1 fell within the
normal confidence interval for in vivo embryos with a few having significantly
upregulated expression (Figure 3.4 and Table 3.5).
Experiment 2: Effect of Protein Source Utilized on Gene Expression Levels
Embryo Development and Cell Number
There was no significant difference in cleavage rate or in the number of 8-16 cell
embryos present 72 hpi in any of the four treatments (KSOMaa or SOFaa with and
without CS) analyzed. The percentage of blastocysts, calculated from the total number
of cleaved embryos, was also not significantly different among the treatments (Tables
3.6 and 3.7).
The mean total cell number and mean ICM cell number in blastocysts at day 7
cultured in KSOMaa with CS (151 ± 9.3and 48 ± 3.1, respectively) was significantly
higher than the mean total cell number and mean ICM cell number of day 7 in vivo
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B
3.5

n-fold difference of Nanog

n-fold difference of Oct 4

A
b

3.0
2.5
2.0
1.5

a
a

1.0
0.5
0.0
In Vivo

0.010
0.008
0.006
0.004
0.002
0.000

SOFaa KSOMaa

In Vivo

Treatment

SOFaa KSOMaa
Treatment

n-fold difference of Glut-1

C
0.6
0.5
0.4
0.3
0.2
0.1
0.0
In Vivo

SOFaa KSOMaa
Treatment

Figure 3.3 Average relative transcript levels for in vivo embryos (black bars) compared to
IVP blastocysts cultured for 7 days in SOFaa (light gray bars) or KSOMaa (dark gray
bars). Relative abundance levels for Oct-4 (A), Nanog (B), and GLUT-1 (C). Bars
indicate SEM. Statistical differences were determined by One-Way ANOVA (P<0.05).
a,b

Significant differences between treatments.
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B
6

n-fold difference of Nanog

n-fold difference of Oct 4

A
5
4
3
2
1
0
SOFaa

0.016
0.014
0.012
0.010
0.008
0.006
0.004
0.002
0.000
SOFaa

KSOMaa

KSOMaa

Treatment

Treatment

n-fold difference of Glut-1

C
2.5
2.0
1.5
1.0
0.5
0.0
-0.5
SOFaa

KSOMaa

Treatment

Figure 3.4 Relative transcription levels of IVP blastocysts on day 7 of culture in either
SOFaa or KSOMaa. Relative levels of Oct-4 (A), Nanog (B), and GLUT-1 (C) on day 7.
Dashed lines represent the 95% confidence intervals for in vivo embryos.
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Table 3.5 Number of IVP blastocyst pools cultured in either KSOMaa or SOFaa that fall within
or out of the 95% CI range for in vivo embryo pools.
Gene

Comparison to In Vivo CI

KSOMaa

SOFaa*

Oct-4

Upregulated
Normal
Downregulated

4
4
2

0
4
4

Nanog

Upregulated
Normal
Downregulated

4
4
2

2
5
1

GLUT-1

Upregulated
Normal
Downregulated

2
8
0

2
6
0

*Note: 10 pools of SOFaa blastocysts were analyzed, but 2 of the blastocyst pools were rejected due to
lack of the poly(A) transcript.
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Table 3.6 Embryonic development of IVP embryos cultured in KSOMaa with or without CS.
Blastocysts† (%)
Clvd
8-16 cell*
Treatment
n
From Clvd
From 8-16 cell
(%)
(%)
KSOMaa

527

401 (76)

129 (25)

76 (19)

76 (59)a

KSOMaa + CS

429

336 (78)

84 (20)

67 (20)

67 (80)b

*8-16 cell embryo 72 h post insemination.
†
Total blastocysts at day 8.
a,b
Different letters within columns indicate significant difference between treatments.
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Table 3.7 Embryonic development of IVP embryos cultured in SOFaa with or without CS.
Blastocysts† (%)
Clvd
8-16 cell*
Treatment
n
From Clvd
From 8-16 cell
(%)
(%)
SOFaa

381

302 (79)

116 (31)

53 (18)

53 (46)

SOFaa + CS

372

283 (76)

100 (27)

57 (20)

57 (57)

*8-16 cell embryo 72 h post insemination.
†
Total blastocysts at day 8.
No significant differences between treatments.
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embryos (100.8 ± 11.9 and 69.3 ± 8.6, respectively). There was no significant difference
in mean trophectoderm cell number or ICM:TE ratio for any treatment (Tables 3.8 and
3.9). Mean cell numbers for day 7 blastocysts was also compared with data collected
from day 8 blastocysts (Tables 3.10 and 3.11). There was a significant difference in
mean ICM number among day 7 and day 8 KSOMaa with CS blastocysts when
compared with all other IVP treatments. There was a also a significant difference in
mean total cell number and mean trophectoderm number among day 7 and 8 SOFaa
blastocysts when compared to all other IVP treatments. Additionally, there was a
significant difference in mean ICM:TE ratio among day 7 and day 8 SOFaa with CS
blastocysts when compared with all other IVP treatments (Figures 3.5 and 3.6).
Transcription Levels in Pre-implantation Embryos
Transcript levels for oct-4 were detected at significantly higher levels in day 7
KSOMaa with CS cultured IVP blastocysts when compared with KSOMaa cultured and
in vivo embryos. There was no significant difference in relative nanog abundance levels
across treatment groups. Connexin 43 was detectable in SOFaa, SOFaa with CS, and
KSOMaa cultured blastocysts in contrast to in vivo embryos. However, blastocysts
cultured in either SOFaa with CS or KSOMaa exhibited significantly higher GLUT-1
transcript levels than their treatment counterparts or in vivo embryos (Figures 3.7 and
3.8).
As in Experiment 1, confidence levels for in vivo embryos were calculated to
better interpret the data. A significant amount of KSOMaa and KSOMaa with CS cultured
blastocysts displayed upregulation of the oct-4 transcript (88% and 90%, respectively)
when compared with in vivo levels. Only 33% of the SOFaa cultured blastocysts and
30% of the SOFaa with CS blastocysts displayed normal levels of nanog. Additionally,
60% of the IVP blastocysts cultured in KSOMaa with CS displayed abnormal levels of
nanog. All of the blastocysts cultured in KSOMaa and 60% of those cultured in KSOMaa
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Table 3.8 Cell number of blastocysts after 7 days of in vivo or in vitro culture in KSOMaa with or
without CS.
Treatment

n

ICM

TE*

ICM:TE

KSOMaa

14

36 ± 3.6a,b

88 ± 8.7

1:2.6 ± 0.2

123 ± 11a,b

KSOMaa + CS

12

48 ± 3.1a

102 ± 6.7

1:2.2 ± 0.1

151 ± 9.3a

In vivo

10

32 ± 3.4b

69.3 ± 8.6

1:2.2 ± 0.1

100.8 ± 11.9b

Statistical differences were determined by One-Way ANOVA (P<0.05).
*TE = Trophectoderm
Data presented as mean ± SEM.
a,b
Different letters within columns indicate significant difference between treatments.

63

Total Cells

Table 3.9 Cell number of blastocysts after 7 days of in vivo or in vitro culture in SOFaa with or
without CS.
Treatment

n

ICM

TE*

ICM:TE

SOFaa

7

41 ± 5.8

79 ± 6.0

1:2.1 ± 0.3

120 ± 10.2

SOFaa + CS

7

39 ± 4.1

100 ± 16

1:2.5 ± 0.3

142 ± 19.8

In vivo

10

32 ± 3.4

69.3 ± 8.6

1:2.2 ± 0.1

100.8 ± 11.9

Statistical differences were determined by One-Way ANOVA (P<0.05)
*TE = Trophectoderm
Data presented as mean ± SEM.
No significant differences between treatments.
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Total Cells

Table 3.10 Cell number of IVP blastocysts after 8 days of culture in KSOMaa with or without CS.
Treatment

n

ICM

TE*

KSOMaa

8

28 ± 2.7

59 ± 5.0

1:2.2 ± 0.2

87 ± 6.8

KSOMaa + CS

11

25 ± 2.3

45 ± 4.8

1:1.8 ± 0.1

70 ± 6.6

Statistical differences were determined by t-test (P<0.05).
*TE = Trophectoderm
Data presented as mean ± SEM.
No significant differences between KSOMaa treatments.
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ICM:TE

Total Cells

Table 3.11 Cell number of IVP blastocysts after 8 days of culture in SOFaa with or without CS.
Treatment

n

ICM

TE*

SOFaa

10

37 ± 2.4

65 ± 4.9

1:2.0 ± 0.2

101 ± 6.1

SOFaa + CS

11

31 ± 2.5

59 ± 7.0

1:1.9 ± 0.2

90 ± 9.0

Statistical differences were determined by t-test (P<0.05).
*TE = Trophectoderm
Data presented as mean ± SEM.
No significant differences between SOFaa treatments.
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Figure 3.5 Differential staining cell numbers for in vivo embryos compared to KSOMaa
blastocysts cultured with or without CS for 7 days (dark gray bars) and 8 days (light gray
bars). Mean ICM cell number (A), mean trophectoderm (TE) cells (B), mean ICM:TE
ratio (C), and mean total cell number (D). Bars indicate SEM. Statistical differences were
determined by One-Way ANOVA (P<0.05).
a,b

Significant differences within treatments between days.
Significant differences between treatments within days.

1,2

*Mean values are given as 1:TE cell ratio.
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Figure 3.6 Differential staining cell numbers for in vivo embryos compared to SOFaa
blastocysts cultured with or without CS for 7 days (dark gray bars) and 8 days (light gray
bars). Mean ICM cell number (A), mean trophectoderm (TE) cells (B), mean ICM:TE
ratio (C), and mean total cell number (D). Bars indicate SEM. Statistical differences were
determined by One-Way ANOVA (P<0.05).
a,b

Significant differences within treatments between days.

*Mean values are given as 1:TE cell ratio.
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Figure 3.7 Average relative transcript levels for in vivo embryos (dark gray bars)
compared to KSOMaa (light gray bars) blastocysts cultured with or without CS for 7
days. Relative abundance levels for Oct-4 (A), Nanog (B), Connexin 43 (C), and GLUT-1
(D). Bars indicate SEM. Statistical differences were determined by One-Way ANOVA
(P<0.05).
a,b

Significant differences between treatments.
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Figure 3.8 Average relative transcript levels for in vivo embryos (dark gray bars)
compared to SOFaa (light gray bars) blastocysts cultured with or without CS for 7 days.
Relative abundance levels for Oct-4 (A), Nanog (B), Connexin 43 (C), and GLUT-1 (D).
Bars indicate SEM. Statistical differences were determined by One-Way ANOVA
(P<0.05).
a,b

Significant differences between treatments.
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with CS displayed higher expression levels of GLUT-1 than the in vivo controls. In
addition, 91% of the SOFaa with CS blastocysts were significantly upregulated for
GLUT-1. Overall, dysregulation of these transcripts was more commonly detected in the
KSOMaa treatments than in the SOFaa treated blastocysts (Figure 3.9 and Table 3.12).

Discussion
Numerous reports have demonstrated that the in vitro production environment
affects the gene expression pattern in the resulting embryos (Wrenzycki et al., 1996,
1999, 2001, 2004; Eckert and Niemann, 1998; Lazzari et al., 2002; Rizos et al., 2002,
2003; Lonergan et al., 2003). This is observed not only when comparing IVP embryos to
in vivo embryos but also between IVP systems. Studies examining the effects of various
medium components or additives generally focus on the blastocyst rate and possibly on
average cell number. While these data points indicate successful development, they fail
to accurately imply developmental competence post-transfer of the blastocyst into a
recipient. By combining traditional measures of developmental capacity (cleavage and
blastocyst rates) with more quantitative measures such as relative mRNA abundance
levels, a more detailed description of the consequences of a given culture environment
may be apparent. The present study focused on the effects of different culture systems
and protein sources on the development of IVP embryos measured by cleavage and
blastocyst rates, cell number, and relative abundance levels of oct-4, connexin 43,
nanog, and GLUT-1.
It has been stated that embryos have a tremendous capability to compensate for
suboptimal culture conditions. Morphologically the blastocysts may appear to develop
normally and at the same rate; however, differences may be detected at the transcript
level. This was apparent in both experiments. Despite similar cleavage and blastocyst
rates among treatments, significant differences were observed at the mRNA level. This
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Figure 3.9 Relative transcription levels of IVP blastocysts on day 7 of culture in either
SOFaa or KSOMaa with or without CS. Relative differences of Oct-4 (A), Connexin 43
(B), Nanog (C), and GLUT-1 (D) on day 7. Dashed lines represent the 95% confidence
intervals of in vivo embryos.
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Table 3.12 Number of IVP blastocyst pools cultured in either KSOMaa or SOFaa with or without
CS that fall within or out of the 95% CI range for in vivo embryo pools.
Gene

Comparison to
in vivo CI

KSOMaa*

KSOMaa + CS*

SOFaa*

SOFaa + CS

Oct-4

Upregulated
Normal
Downregulated

8
1
0

9
1
0

4
1
4

6
4
1

Nanog

Upregulated
Normal
Downregulated

3
5
1

2
4
4

2
3
4

0
3
8

Connexin 43

Upregulated
Normal
Downregulated

5
4
0

0
10
0

3
6
0

2
9
0

GLUT-1

Upregulated
Normal
Downregulated

9
0
0

6
4
0

4
5
0

10
1
0

*Note: 11 pools of blastocysts were analyzed for each treatment. However, 2 of the KSOMaa, 1 of the
KSOMaa with CS, and 2 of the SOFaa blastocyst pools were rejected due to lack of the poly(A) transcript.
Only 10 in vivo blastocyst pools were analyzed.
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was in agreement with data collected by Wrenzycki et al. (2001) and others. Cleavage
rates also did not differ between media supplemented with BSA or CS, which is in
agreement with previous reports (Eckert and Niemann, 1995; Lonergan et al., 1999;
Rizos et al., 2003). Differences were evident when comparing cell numbers between
treatments in Experiment 1. Differential staining revealed differences among treatments
in Experiment 2 for only ICM and total cell number data. Differences in cell number data
were observed among treatments in both experiments when comparing day 7 and day 8
blastocysts.
KSOMaa has a significantly higher concentration of potassium and lactic acid
than SOFaa. SOFaa has a significantly higher concentration of glucose and an overall
higher osmolarity than KSOMaa. These differences in media composition attribute to the
differences observed in gene expression levels.
In the first experiment, oct-4 was the only gene found to have a mean transcript
level significantly higher in KSOMaa cultured blastocysts when compared to both SOFaa
cultured blastocysts and in vivo embryos. Blastocysts cultured in SOFaa either
expressed oct-4 at normal levels or were downregulated as related to in vivo embryos.
The same pattern of upregulation of oct-4 in KSOMaa or KSOMaa with CS cultured
blastocysts was observed in the second experiment. In Experiment 1, KSOMaa cultured
blastocysts had a significant increase in ICM cells when compared to in vivo blastocysts,
but were not significantly different to ICM cells present in SOFaa cultured blastocysts.
Therefore, this upregulation is not exclusively attributed to the additional ICM cells
present in KSOMaa and KSOMaa with CS treated blastocysts when compared to both
SOFaa and in vivo embryos. The difference in ICM number may be a contributing factor
to the increase in oct-4 expression, but it is not the only causative agent. We
hypothesize that this increase in oct-4 expression may be due to the differences in
media composition. The lower osmolarity level and higher potassium and lactic acid
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concentrations present in KSOMaa when compared with SOFaa could be increasing the
pluripotency status of the ICM cells through increased transcription rates, thus
stimulating oct-4 expression. High osmolarity has been shown to induce osmotic stress
in embryos that is thought to alter the expression of various genes. The lower osmolarity
level in KSOMaa may relieve osmotic stress in the ICM cells allowing for the increase in
oct-4 expression. Additionally, numerous reports have indicated that bovine IVP
blastocysts generally express oct-4 variably. The contrasting results we observed
between the KSOMaa and SOFaa treatments are in accordance with reports of Li et al.
(2005) who stated that IVP embryos can exhibit either upregulation or downregulation of
the oct-4 gene, suggesting that the developmental competence of the embryos is
already compromised at the blastocyst stage.
Nanog transcription in stem cells appears to be controlled by the synergistic
actions of oct-4 and the Sox binding proteins (Yamaguchi et al., 2005). Therefore, we
would expect nanog to be expressed in a similar pattern to oct-4. Our results indicate
otherwise. Unlike the differences detected between treatment groups in oct-4, there was
no significant upregulations or downregulations of nanog in either experiment. This was
unexpected since nanog is thought to be ICM specific and differences were observed in
oct-4 expression. Due to the lack of variation in nanog expression, we hypothesize that
oct-4 would be the better ICM specific candidate gene to analyze responses to in vitro
culture environments. Degrelle et al. (2005) found nanog to be expressed in all
embryonic and extra-embryonic tissues in later stages of development (12 to 17 days
post-insemination), but was restricted to the ICM of earlier stage blastocysts.
mRNAs encoding connexin 43 are first detectable from the 4-cell stage onwards
(Wrenzycki et al., 1998) and expression decreases slightly thereafter. Connexin 43
peaks in expression at the compacted morula stage and is somewhat downregulated at
the blastocyst stage (Rizos et al., 2002). Previous work has shown that the connexin 43
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gene is transcribed only up to the morula stage in IVP bovine embryos whereas the
transcript is present in in vivo derived, cocultured, and ewe oviduct cultured bovine
morulae and blastocysts (Wrenzycki et al., 1996; Rizos et al., 2002, 2003). However,
connexin 43 was not expressed at detectable levels in in vivo embryos analyzed in our
studies. It is well accepted that in vivo derived embryos collected at a particular time can
vary in development as much as 12-24 h or even greater. In vivo embryos collected in
our studies varied in development from the early morula stage to the late blastocyst
stage. Due to the variability in development, we propose that connexin 43 expression
would also be variable or possibly faulty. As expected, connexin 43 was not detected in
IVP blastocysts used in Experiment 1. Conversely, connexin 43 was detected in
KSOMaa, SOFaa, and SOFaa with CS cultured blastocysts in Experiment 2. These
variable results and the lack of connexin 43 in our in vivo embryos are likely due to
differences in relation to time of development. Q-PCR measures relative abundance
levels at a specific time point. Different results could be expected if embryos were
collected as little as a few hours earlier or later. Our results indicate that the presence of
serum in IVP embryos significantly downregulated the connexin 43 gene. This concurs
with Lonergan et al. (2003) who reported that connexin 43 was altered in vitro by the
presence of serum, disappearing at the 8- to 16-cell stage and reappearing at the
hatched blastocyst stage. Conversely, Wrenzycki et al. (1998) reported that connexin 43
was not affected by the addition of either serum or BSA. The variable reports indicate
that connexin 43 is a sensitive candidate gene to be studied as a marker for determining
the quality of an in vitro culture system.
GLUT-1 increases in expression from the 8-16-cell stage onward coinciding with
the point in development in which embryos become dependent on glucose as an energy
source. Niemann and Wrenzycki (2000) and Wrenzycki et al. (2001) found that the
relative levels of the GLUT-1 transcript were higher in in vivo embryos than IVP
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embryos. Our data does not agree with these reports as in vivo embryos analyzed
expressed low levels of the transcript. This discrepancy is likely due to the variation in
embryonic development observed in the in vivo embryos collected in our experiments.
The low in vivo cell numbers are possibly responsible for the low GLUT-1 abundance
levels observed in the in vivo embryos. The addition of serum to culture media
significantly upregulates GLUT-1 in IVP embryos (Wrenzycki et al., 1999). In contrast, de
Oliveira et al. (2006) did not detect any significant differences among in vivo and IVP
embryos supplemented with different protein sources and serum concentrations. Data
presented in this study demonstrates that blastocysts cultured in SOFaa with CS have a
significant upregulation of GLUT-1 when compared to other treatments and in vivo
embryos. As stated before, GLUT-1 transports glucose into embryonic cells and SOFaa
medium has a higher concentration of glucose than KSOMaa medium. Therefore, we
hypothesize that the upregulation of GLUT-1 in SOFaa with CS is attributed to both the
high glucose content present in SOFaa and the stimulatory effects of CS. KSOMaa
cultured IVP blastocysts also expressed GLUT-1 at significantly higher levels. In all
treatments analyzed in Experiment 2, the majority of blastocysts expressed GLUT-1 at
higher levels than the in vivo control range. Therefore, we hypothesize that under certain
in vitro conditions embryos can be produced with high levels of GLUT-1 transcript. It
should also be noted that we observed variation in the expression of GLUT-1 both
between treatments and between replicates within treatments. This suggests that the
lack of statistical significance in some treatments (specifically KSOMaa in the first
experiment) could be due to greater variation between embryo pools. Due to variable
results reported by our group and others when analyzing GLUT-1, this transcript should
be further investigated.
In most experiments measuring the effects of the in vitro culture environment on
development a control, usually a “normal” embryo, is used. We generally accept in vivo
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derived embryos as “normal.” However, not all in vivo embryos collected (generally on
day 7) are “normal”. If embryos are flushed from the cow at day 7 and transferred to
recipient cows not all embryos transferred will make it to term. In fact, pregnancy rates
from transferred in vivo derived embryos can range anywhere between 50 to 75% (Farin
et al., 1999). As stated before, in vivo derived embryos collected at a particular time can
vary in development as much as 12 to 24 h or greater. IVP embryos are precisely timed
off IVF. Our cell number data demonstrates that IVP blastocysts have a greater number
of total cells than in vivo blastocysts. This is likely due to differences in development
between day 7 IVP and in vivo embryos. This difference exposes the problem in
comparing IVP with in vivo embryos in regards to the effects of culture conditions. Our
data indicates that not all in vivo derived embryos are equal in developmental status and
some may not be viable in early stage embryonic development. Nevertheless, in vivo
embryos are the accepted standard because they are as close to “normal” as we can
get. It is also of common practice to report IVP blastocyst rates after 8 days of in vitro
culture. We clearly demonstrate that blastocysts not developing until day 8 of culture are
not equal to blastocysts developing after only 7 days of culture. In both experiments,
differences were observed in cell numbers between day 7 and day 8 IVP blastocysts
irrespective of culture treatment. Day 8 blastocysts had significantly lower cell numbers
than day 7 blastocysts. It is likely that these day 8 blastocysts are not viable. Therefore,
by reporting blastocyst rates after 8 days of in vitro culture, a higher rate is achieved;
however, this rate does not accurately reflect viable blastocysts.
Our results indicate that the transcript levels of the majority of the genes
analyzed were significantly altered by the in vitro culture condition. We and others
(Wrenzycki et al., 2001; Lonergan et al., 2006) hypothesize that bovine embryos
respond to alterations in their environment by modifying the expression levels of several
developmentally important transcripts. The findings of this study not only have
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applications to the field of IVP in animals, but also to human assisted reproduction
technologies. To ensure the delivery of normal and healthy offspring, research must be
conducted to improve the in vitro culture environment. The basic mechanisms that take
place during the pre-implantation period and the effects that culture components may
have on the resulting embryo are still unknown. Differences continue to be found
between in vitro cultured and in vivo embryos, and until these differences are minimized,
aberrations in in vitro development will continue to be observed. Further research will
possibly modify the current culture conditions during this critical period of development
allowing for the production of in vitro embryos of higher developmental potential similar
to that noted in in vivo derived embryos.
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CHAPTER IV
SUMMARY AND CONCLUSIONS
Numerous studies have reported aberrant gene expression levels attributed to
suboptimal or even nonphysiological in vitro culture conditions presented to embryos
(Wrenzycki et al., 1996, 1999, 2001, 2004; Eckert and Niemann, 1998; Lazzari et al., 2002;
Rizos et al., 2002, 2003; Lonergan et al., 2003). Current culture systems can also lead to either
persistent silencing or enhanced expression of a particular gene throughout preimplantation
development (Wrenzycki et al., 2001). Lonergan et al. (2003) indicated that any modifications to
the in vitro culture environment can have profound effects on the quality of the resulting
embryos measured in terms of cryotolerance and relative transcript abundance. Since the
culture environment is the common aspect of both in vitro production (IVP) and nuclear transfer
(NT), research focusing on the in vitro culture system will not only better IVP but NT also.
However, little thought is often given to what implications could arise from using these artificial
technologies in terms of its effects on gene expression.
The present studies focused on the effects of different culture systems and protein
sources on the developmental competence of IVP embryos measured by cleavage and
blastocyst rates, cell number, and relative abundance levels of oct-4, nanog, connexin 43, and
GLUT-1. All data points were compared with those found in in vivo embryos. Experiment 1
compared IVP embryos cultured in either synthetic oviductal fluid (SOFaa) or potassium simplex
optimized medium (KSOMaa) supplemented with amino acids. Experiment 2 compared the
same two culture systems with and without the addition of calf serum (CS). Results from both
experiments indicated that despite similar cleavage and blastocyst rates among treatments,
significant differences were found at the mRNA level. In addition, differences were evident when
contrasting cell number data between treatments in Experiment 1. Differential staining revealed
differences among treatments in Experiment 2 for only ICM and total cell number data.
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In the first experiment, oct-4 was the only transcript found to have a mean abundance
mRNA level significantly higher in KSOMaa cultured blastocysts when compared to both SOFaa
cultured blastocysts and in vivo embryos. As expected, the same pattern of upregulation of oct4 in KSOMaa or KSOMaa with CS cultured blastocysts was observed in the second experiment.
Unlike the differences detected between treatment groups in oct-4 expression, there was no
significant upregulations or downregulations of the ICM specific transcript nanog in either
experiment. In contrast to reports by others (Wrenzykci et al., 1996; Rizos et al., 2002, 2003),
connexin 43 was not expressed at detectable levels in in vivo embryos analyzed in our studies.
As expected, connexin 43 was not detected in IVP blastocysts used in Experiment 1.
Conversely, connexin 43 was detected in KSOMaa, SOFaa, and SOFaa with CS cultured
blastocysts in Experiment 2. These variable results indicate that connexin 43 is a sensitive
candidate gene to be studied as a marker for determining the quality of an in vitro culture
system. In vivo embryos analyzed expressed low levels of GLUT-1 contrary to other reports.
Data presented in this study also demonstrated that blastocysts cultured in SOFaa with CS had
a significant upregulation of GLUT-1 when compared with other treatments and in vivo embryos.
Additionally, KSOMaa cultured IVP blastocysts also expressed GLUT-1 at significantly higher
levels. Due to variable results observed by our group and others when analyzing GLUT-1, this
transcript should also be further investigated. The variable results obtained in these studies are
likely the effects of the inconsistency in expression levels observed with relation to time of
development. Q-PCR measures relative abundance levels at a specific time point. Different
results could be expected if embryos were collected as little as a few hours earlier or later.
Our cell number data demonstrates that IVP blastocysts have a greater number of total
cells than in vivo blastocysts, in contrast to other reports. This is likely due to differences in
development between day 7 IVP and in vivo embryos. This difference exposes the problem in
comparing IVP with in vivo embryos in regards to the effects of culture conditions. We also
clearly demonstrate that blastocysts not developing until day 8 of culture are not equal to
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blastocysts developing after only 7 days of culture. In both experiments, day 8 blastocysts had
significantly lower cell numbers than day 7 blastocysts. It is likely that these day 8 blastocysts
are not viable. Therefore, by reporting blastocyst rates after 8 days of in vitro culture, a higher
rate is achieved; however, this rate does not accurately reflect viable blastocysts.
By combining traditional measures of developmental capacity (cleavage and blastocyst
rates) with more quantitative measures such as relative mRNA abundance levels, a more
detailed description of developmental competency is achievable. Our results indicate that the
transcript levels of the majority of the genes analyzed were significantly altered by an in vitro
culture condition. The findings of this study not only have applications to the field of IVP in
animals but also to human assisted reproduction technologies. The basic mechanisms that take
place during the preimplantation period and the effects that culture components may have on
the resulting embryo are still unknown. Differences continue to be observed between in vitro
cultured and in vivo embryos, and until these differences are minimized, aberrations in in vitro
development will continue to be observed. Further research will possibly modify the current
culture conditions during this critical period of development allowing for the production of in vitro
embryos of higher developmental potential similar to that observed in in vivo derived embryos.
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APPENDIX A: PROTOCOLS
BOVINE IVF PROTOCOL
Preparations:
1. Move PHE (100 μl) (Appendix B) and Heparin (100 μl) (Appendix B) from freezer
to oven (39°C). PHE should be covered with aluminum foil (light sensitive).
2. Move two centrifuge carriers to oven (39°C).
3. Make fertilization microdrops
a. Make five 44 μl drops of IVF-TALP in each 35mm dish. Cover with prewarmed and pre-gassed mineral oil.
b. Equilibrate in CO2 incubator (39°C) at least 2 h.
4. Fill 1 conical tube with ~5 ml of IVF-TALP (Appendix B). Label tube.
5. Fill 1 conical tube with ~20 ml HEPES-TALP (Appendix B). Label tube.
6. Fill 1 conical tube with 5 ml Sperm-TALP (Appendix B). Label tube.
7. Transfer tube of HEPES-TALP (cap tight) and SP-TALP (cap tight) to the 39°C
oven.
8. Transfer IVF-TALP (cap loose) to CO2 incubator.
9. Prepare Percoll gradient:
a. Label 1 conical tube “Percoll gradient” and fill the tube with 100 μl of
Sperm-TL and 900 μl of ENHANCE-S Plus.
10. Carefully, transfer Percoll gradient to the pre-warmed centrifuge carrier within the
oven.

Procedures:
1. At 22-24 h post-maturation thaw 1 straw of semen in water at 39°C for 30
seconds. When getting semen straws out of the liquid nitrogen tank, make sure
not to raise anything above the frost line. Use special semen forceps.
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2. Dry a straw, hold it in a kimwipe to keep it warm and dark, cut the sealed end off
and slowly layer thawed semen on top of the Percoll gradient by gently pushing
the plug in the straw with a metal rod. Place the conical tube back into the
centrifuge carrier and centrifuge at 1200 rpm for 20 min.
3. Check viability of the thawed semen by placing a drop remaining in the straw on
a slide. View at 40X magnification to assure that motile sperm are present.
4. While centrifuge is running, pour 2 ml of HEPES-TALP (from conical tubes in
CO2 oven) into Petri dish (35 mm). Remove oocytes from each well of OMM
plate/vial and transfer to a separate corner in the HEPES-TALP. Thoroughly
wash oocytes through 2 dishes of HEPES-TALP to remove OMM, which is
detrimental to fertilization.
5. Transfer up to 10 oocytes into each 44 μl fertilization drop or 425 µl in 4-well dish
(IVF-TALP, previously located in the incubator). Return IVF plate back to
incubator when finished. *You only have 15 min to wash and transfer all oocytes
to IVF 4-well plates. Set a timer and ask for help if necessary.
6. After centrifuge stops, carefully remove carrier with the Percoll gradient from
centrifuge. There should now be a sperm pellet, if not you must start completely
over with new gradient and semen.
7. Within the laminar flow hood, aspirate the Percoll down to the sperm pellet.
Slowly add the 5 ml of pre-warmed Sperm-TALP to the conical tube containing
the sperm pellet. Transfer the tube to the second pre-warmed centrifuge carrier
and centrifuge at 1200 rpm for an additional 10 min.
8. After the centrifuge stops, aspirate the Sperm-TALP down to the sperm pellet.
Return the conical tube with the sperm pellet to the oven.
9. Determine Sperm Pellet Concentration
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A. Gently swirl the sperm pellet to mix the sperm with any remaining
medium. Use a clean pipette tip to transfer 5 μl of sperm into 95 μl of
water, pipetting gently to mix.
B. Clean the hemocytometer and coverslip by washing with water followed
by 70% EtOH; dry with a Kimwipe.
C. Using a new pipette tip, transfer 10 μl of diluted sperm into each
chamber (each side) of the hemocytometer
D. Use 40X magnification to count sperm cells in the 5 squares arranged
diagonally across the central square on one side of the hemocytometer.
Use an event counter to keep track of how many cells are counted.
Record the count.
E. Continue counting on the second side of the hemocytometer counting 5
diagonally arranged squares to obtain the total hemocytometer count. If
the count of one side varies more than 10% from the other side, then
the diluted sample was not properly mixed. Repeat procedure starting
at step 1. When the count is consistent, record the total count and
continue procedure.
F. Clean hemocytometer and coverslip with water followed by EtOH.
10. Preparing sperm suspension for insemination (See “Explanation of Sperm
Suspension”)
Note: The final sperm suspension used to IVF is composed of fertilization
medium and sperm pellet produced by Percoll separation. A worksheet is
attached and can be duplicated and used to assist in calculating sperm
suspensions. The calculations on the worksheet are modified from those listed
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below, although the equations may appear different, they will yield identical
results. Following the worksheet will simplify this procedure.
A. Calculations are based on the following parameters:
a. 300 μl of final sperm suspension will be prepared
b. 1 x 106 sperm/ml is desired in the final fertilization medium
(this concentration can be adjusted if needed using Step 3
below)
B. Calculate the volume of sperm pellet needed per 300 μl of final sperm
suspension using the formula:
7,500/X = μl of sperm pellet to make 300 μl of final sperm suspension
when inseminating with 1 x 106 sperm/ml
When X is the average hemocytometer count (total hemocytometer
count divided by 2)
C. Adjust for desired sperm concentration: If a concentration other than 1 x
106 sperm/ml is desired, then the volume of the sperm pellet must be
adjusted to accommodate that difference. To adjust this volume
perform the following calculation:
Sperm concentration desired/1 x 106 sperm/ml = sperm concentration
adjustment factor
Multiply the volume of the sperm pellet calculated in Step 2 by this
adjustment factor to yield the volume sperm pellet needed to prepare
300 μl of final sperm suspension at the desired concentration.
Example: If a bull requires are 2 x 106 sperm/ml rather than 1 x 106
sperm/ml
2 x 106 sperm/ml / 1 x 106 sperm/ml = adjustment factor of 2
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(Adjustment factor) x (μl of pellet needed for 1 x 106 sperm/ml) = μl of
sperm pellet needed to yield 2 x 106 sperm/ml in 300 μl of final sperm
suspension providing 2 x 106 sperm/ml in the fertilization drop.
D. Calculate volume of fertilization medium needed in the final sperm
suspension: Subtract the volume found in Step 3 from 300 μl from Step
1.
E. Place the calculated amount of fertilization medium (Step 4) into and
Eppendorf microcentrifuge tube. Then add the calculated amount of
sperm pellet (Step 3) to the tube. Sperm stick to plastic, so add the
fertilization medium to the tube first. Mix gently by pipetting up and
down several times within the tube. Immediately begin fertilizing the
drops since the pH of this solution sill change rapidly.
11. Fertilization
A. Add 2 μl heparin (for a final concentration of 2 μg/ml of heparin in the
fertilization medium), 2 μl of PHE and 2 μl of final sperm suspension to
each drop. If 4-well dish was used, add 20 µl heparin, 20 µl PHE and
20 µl sperm.
B. Record time and date on each fertilization dish.
C. Incubate for 17 to 18 h at 39°C in a humidified atmosphere of 5% CO2
in air.
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DIFFERENTIAL STAINING PROTOCOL
1. Wash day 7 or day 8 embryos in dPBS with Ca and Mg.
2. Incubate the embryos with 10 μl of Hoechst stock solution (Appendix B) plus 500 μl
dPBS with Ca and Mg for 10 min.
3. Permeabilize the membranes with 500 μl of 0.04% Triton X-100 (Appendix B) solution
for 1 min.
4. Incubate the embryos with 20 μl of PI stock solution (Appendix B) plus 500 μl of dPBS
with Ca2+ and Mg2+ for 45 sec.
5. Wash embryos in 500 μl dPBS with Ca2+ and Mg2+.
Note: Steps 2-5 can be performed in a 4-well dish.
6. Mount the embryos onto a glass microscope slide in a drop of 25% glycerol.
7. Gently flatten the embryos with a coverslip.
8. Count number of cells using an epifluorescent microscope equipped with an UV filter
cube.
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SOMATIC CELLS RNA ISOLATION PROTOCOL
1. Store cells in the minimum possible amount of PBS plus 0.1% polyvinyl alcohol in 1.5
ml siliconized tubes.
2. Bring Dynabeads mRNA® DIRECT™ Kit (Dynal Biotech, Inc., Lake Success, NY,
USA, Cat No. 610.11) to room temperature.
3. Lyse the embryos in 1250 μl of lysis/binding buffer (100 mM Tris HCl pH 8.0, 500 mM
LiCl, 10 mM EDTA, 1% lithium dodecylsulfate, 5 mM dithiothreitol).
4. Shear RNA with 21 g needle 3 to 5 times using a 1 to 2 ml syringe and vortex for 10
sec.
5. Add 250 μl of pre-washed oligo dT Dynabeads (dT25) to the sample. Pre-wash beads
in lysis/binding buffer.
6. Incubate the Dynabeads and sample by rotating on a mixer or roller for 10 min at
room temperature.
7. Place the tubes in a magnetic separator for 2 min.
8. After removal of the supernatant, wash the beads two times with 1 ml of buffer A (10
mM Tris HCl (pH 8.0), 150 mM LiCl, 1 mM EDTA, 0.1% lithium dodecylsulfate) and three
times with 1 ml of buffer B (10 mM Tris HCl (pH 8.0), 150 mM LiCl, 1 mM EDTA).
9. Elute the RNA from the beads by adding 11 μl of sterile water and heating the sample
at 75°C for 2 min.
10. Use the sample directly for reverse transcription.

101

EMBRYO RNA ISOLATION PROTOCOL
1. Store pools of embryos (10 embryos per pool for Experiment 1 and 5 embryos per
pool for Experiment 2) in approximately 3 μl of PBS plus 0.1% polyvinyl alcohol in 1.5 ml
siliconized tubes.
2. Bring Dynabeads mRNA® DIRECT™ Kit (Dynal Biotech, Inc., Lake Success, NY,
USA, Cat No. 610.11) to room temperature.
3. Lyse the embryos in 150 μl of lysis/binding buffer (100 mM Tris HCl, pH 8.0, 500 mM
LiCl, 10 mM EDTA, 1% lithium dodecylsulfate, 5 mM dithiothreitol) and vortex for 10 sec.
4. Centrifuge the samples at maximum speed for 15 sec and incubate at room
temperature for 10 min.
5. Add 10 μl of pre-washed oligo dT Dynabeads (dT25) to the sample. Pre-wash beads in
lysis/binding buffer.
6. Incubate the Dynabeads and sample by rotating on a mixer or roller for 10 min at
room temperature.
7. Place the tubes in a Dynal MPC-E-1 magnetic separator for 2 min.
8. After removal of the supernatant, wash the beads once with 100 μl of buffer A (10 mM
Tris HCl (pH 8.0), 150 mM LiCl, 1 mM EDTA, 0.1% lithium dodecylsulfate) and three
times with 100 μl of buffer B (10 mM Tris HCl (pH 8.0), 150 mM LiCl, 1 mM EDTA).
9. Elute the RNA from the beads by adding 11 μl of sterile water and heating the sample
at 75°C for 2 min.
10. Use the sample directly for reverse transcription.

- Protocol from Wrenzycki (1996, 1998, 2001, 2004)
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cDNA SYNTHESIS PROTOCOL
1. Mix 4 μl of iScript reaction mix, 1 μl of reverse transcriptase, 4 μl of nuclease-free
water (Appendix B) (Bio-Rad Laboratories, Inc., Hercules, CA, USA, Cat No. 170-8891).
2. Make master mixers when possible.
3. Add 11 μl of mRNA sample.
4. Extra mix should be prepared for the no mRNA template negative control.
5. Total volume mix should be 20 μl.
6. Place the mix in the thermocycler.
7. Run the thermocycler at 25°C for 5 min, 42°C for 30 min, denaturation at 85°C for 5
min, and a final hold at 4°C.
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RT-PCR PROTOCOL
1. Mix 5 μl of 10X PCR buffer, 1 μl dNTP mix (Appendix B), 2 μl Jump Start™
REDTaq™ DNA Polymerase (Sigma-Aldrich, Inc., St. Louis, MO, USA, Cat. No. D-8187)
and 35 μl of water. Make a bigger volume for multiple samples when necessary (Master
Master Mix-MMM; Appendix B).
2. Add 1 μl of each primer (20 ρmol) to the MMM. Make a bigger volume for multiple
samples when necessary (Master Mix-MM; Appendix B).
3. Add 5 μl of the cDNA sample to the MM (RT-PCR Mix; Appendix B).
4. Save enough MMM and MM for the negative control (no cDNA).
5. Place the samples in the thermocyler.
6. Run one cycle of 1 min at 95°C; 35 cycles of PCR (95°C for 30 sec, 55°C for 30 sec,
and 72°C for 30 sec); followed by 72°C for 4 min; with a final hold at 4°C.
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Q-PCR PROTOCOL
1. Mix 12.5 μl of iQ SYBR™ Green 2X Supermix (Bio-Rad Laboratories, Inc., Hercules,
CA, USA, Cat. No. 170-8882), 4 µl of cDNA/Calibrator/H2O for NT control, 6.5 μl of water
(Reaction Mix; Appendix B) for each well.
2. A master mix per cDNA sample/Calibrator/H2O for NT control enough for all 5 genes
should be formulated (Appendix B).
3. Prepare enough master mix to run negative controls (no cDNA) for each gene
analyzed.
4. Add 1 μl of each primer (20 pmol) (Appendix B) to appropriate wells.
5. Place the sample in the thermocycler.
6. Run one cycle of 3 min at 95°C; 40 cycles of PCR (95°C for 10 sec and 55°C for 45
sec); a melting curve consisting of 95°C for 1 min followed by 55°C for 1 min, a step
cycle with 80 repeats starting at 55°C for 10 sec with a +0.5°C/sec transition rate; and a
final hold at 4°C.
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GENE EXPRESSION QUANTIFICATION PROTOCOL
1. Use the method described by Pfaffl (2001).
2. Use a mix of cDNA from fibroblast cells, plasmids (Appendix A) and embryos as the
calibrator for the target genes. The same calibrator mix should be used throughout all
the experiments and plates.
3. Use Poly A as the endogenous control gene.
4. Use the signal of the reference gene Poly A to normalize the target gene signals of
each sample.
5. Calibrate the ΔCT for gene transcription against the sample used as calibrator.
6. Report gene quantification as relative transcription or the n-fold difference relative to a
calibrator.
7. Calculate the relative linear amount of target molecules relative to the calibrator by
using the following equation.
n-fold difference =

Efficiency Target GeneΔCTT _
Efficiency Reference GeneΔCTR

8. Efficiencies are obtained via a 10-fold dilution standard curve performed prior to
analysis.
9. Calculate the ΔCTT value by subtracting the sample CT value of the target gene from
the calibrator CT value of the target gene.
10. Calculate the ΔCTR value by subtracting the sample CT value of the reference gene
(Poly A) from the calibrator CT value of the reference gene.
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PLASMID FORMULATIONS
1. cDNA from PCR analysis was run on a 2% agarose gel. The PureLink™ Quick Gel
Extraction Kit (Invitrogen, Carlsbad, CA, USA, Cat. No. K2100-12) was used to isolate
and obtain the cDNA from the gel. A portion of the purified cDNA was used for sequence
analysis.
a. Cut the area of the gel containing the desired cDNA fragment using a clean,
sharp blade while minimizing the amount of agarose collected around the
sample.
b. Weigh the gel slice and add 30 μl of Gel Solubilization Buffer for every 10 mg
of gel.
c. Incubate the tube at 50°C for 15 min. Pipette the mixture every 3 min to ensure
gel dissolution. After the gel slice has disappeared, incubate for an additional 5
min.
d. Place a Quick Gel Extraction Column into a Wash Tube. Pipette the mixture
from step c onto the column.
e. Centrifuge at >12,000 X g for 1 min. Discard the flow-through.
f. Add 500 μl Gel Solubilization Buffer to the column. Incubate at room
temperature for 1 min. Centrifuge at >12,000 X g for 1 min. Discard the flowthrough.
g. Add 700 μl Wash Buffer with ethanol to the column and incubate at room
temperature for 5 min. Centrifuge at >12,000 X g for 1 min. Discard the flowthrough.
h. Centrifuge the column at >12,000 X g for 1 min to remove any residual buffer.
Place the column into a 1.5 ml recovery tube.
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i. Add 50 μl warm (65-70°C) TE Buffer to center of cartridge. Incubate at room
temperature for 1 min and centrifuge at >12,000 X g for 2 min. Store cDNA at 20°C.
2. The TOPO® XL PCR Cloning Kit (Invitrogen, Carlsbad, CA, USA, Cat. No. K4750-20)
was used to clone the cDNA by generating a plasmid vector.
TOPO® Cloning Reaction:
a. Set up a cloning reaction in a sterile microcentrifuge tube containing 4 µl gelpurified long PCR product and 1 µl pCR®-XL- TOPO® vector.
b. Mix gently and incubate for 5 min at room temperature (~25°C). Do not exceed
5 min!
c. After the 5 min incubation, add 1 µl of the 6X TOPO® Cloning Stop Solution
and mix for several seconds at room temperature.
d. Briefly centrifuge the tube and immediately place on ice.
One Shot® Chemical Transformation:
a. Add 2 µl of the TOPO® Cloning reaction into a vial of One Shot® cells and mix
gently. Do not pipette!
b. Incubate on ice for 30 min and then heat shock cells for 30 sec at 42°C without
shaking.
c. Immediately transfer the tubes to ice and incubate for 2 min.
d. Add 250 µl of room temperature S.O.C. medium.
e. Cap the tube tightly and shake horizontally at 37°C for 1 h.
f. Spread 50 to 150 µl from each transformation onto prewarmed LB agar plates
containing 50 µg/ml kanamycin.
g. Incubate the plates overnight at 37°C.
h. An efficient reaction should produce several hundred colonies.
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3. The plasmid was isolated from a cell culture using the PureLink™ Quick Plasmid
Miniprep Kit (Invitrogen, Carlsbad, CA, USA, Cat. No. K2100-11). Before starting,
preheat an aliquot of TE Buffer to 65-70°C for elution step.
a. Pellet 1 to 5 ml of an overnight culture and thoroughly remove all medium from
the cell pellet.
b. Completely resuspend the pellet in 250 μl Resuspension Buffer with RNase A.
No cell clumps should remain.
c. Add 250 μl Lysis Buffer to cells. Mix gently by inverting the capped tube 5
times. Do not vortex.
d. Incubate the tube for 5 min at room temperature. Do not exceed 5 min.
e. Add 350 μl Precipitation Buffer and mix immediately by inverting the tube until
the solution is homogeneous. Do not vortex.
f. Centrifuge the mixture at ~12,000 X g for 10 min at room temperature to clarify
the lysate from the lysis debris.
g. Load the supernatant from step f onto a spin column.
h. Place the spin column with supernatant into a 2 ml Wash Tube.
i. Centrifuge at ~12,000 X g for 1 min and discard the flow-through.
j. Add 500 μl Wash Buffer with ethanol to the column. Incubate for 1 min at room
temperature, centrifuge at ~12,000 X g for 1 min, and discard the flow-through.
k. Add 700 μl Wash Buffer with ethanol to the column and centrifuge the column
at ~12,000 X g for 1 min discarding the flow-through.
l. Centrifuge the column at ~12,000 X g for 1 min to remove any residual Wash
Buffer. Discard the Wash Tube with the flow-through.
m. Place the spin column in a clean 1.5 ml recovery tube.
n. Add 75 μl preheated TE Buffer to the center of the column and incubate the
column for 1 min at room temperature.
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o. Centrifuge at ~12,000 X g for 2 min
p. The recovery tube will contain the purified plasmid.
4. A Qiagen QIAfilter Plasmid MidiKit (QIAGEN, Inc., Valencia, CA, USA, Cat. No.
12243) was used to isolate a higher yield of plasmid.
a. Pellet 100 ml of an overnight culture by centrifugation at 6000 X g for 15 min at
4°C and thoroughly remove all medium from the cell pellet.
b. Resuspend the bacterial pellet in 4 ml Buffer P1 supplemented with RNase A
and LyseBlue. The bacteria should be resuspended completely by vortexing or
pipetting up and down until no cell clumps remain.
c. Add 4 ml of Buffer P2 and mix thoroughly by vigorously inverting the sealed
tube 4-6 times, and incubate at room temperature (15 to 25°C) for 5 min. Do not
vortex and do not allow the reaction to exceed 5 min! If LyseBlue has been
added to Buffer P1, the reaction will turn blue after the addition of Buffer P2.
d. Add 4 ml of chilled Buffer P3 to the lysate and mix immediately and thoroughly
by vigorously inverting 4 to 6 times. The solution will precipitate and the
precipitated material will contain genomic DNA, proteins, cell debris, and SDS. A
homogeneous colorless suspension indicates that the SDS has been effectively
precipitated. Do not incubate the lysate on ice, proceed immediately!
e. Pour the lysate into the barrel of the QIAfilter Cartridge. Incubate at room
temperature (15 to 25°C) for 10 min. A precipitate containing proteins, genomic
DNA, and detergent will float and form a layer at the top of the solution. Do not
insert the plunger!
f. Equilibrate a QIAGEN-tip 100 by applying 4 ml of Buffer QBT, and allow the
column to empty by gravity flow.
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g. Remove the cap from the QIAfilter Cartridge outlet nozzle and gently insert the
plunger into the QIAfilter Midi Cartridge and filter the cell lysate into the
previously equilibrated QIAGEN-tip.
h. Allow the cleared lysate to enter the resin by gravity flow.
i. Wash the QIAGEN-tip with 10 ml Buffer QC twice.
j. Elute DNA with 5 ml of Buffer QF into a 15 ml tube.
k. Precipitate DNA by adding 3.5 ml room temperature isopropanol to the eluted
DNA. Mix and centrifuge immediately at 5000 X g for 60 min at 4°C. Carefully
decant the supernatant.
l. Wash the DNA pellet with 2 ml room temperature 70% ethanol, and centrifuge
at 5000 X g for 60 min at 4°C. Carefully decant the supernatant without disturbing
the pellet.
k. Air dry the pellet for 5 to 10 min, and redissolve the DNA in a suitable volume
of TE buffer (pH 8.0).

111

IN VIVO EMBRYO PRODUCTION – SYNCHRONIZATION AND
SUPEROVULATION
1. Administer an injection of 15 mg progesterone and 2.5 mg estradiol-17β intramuscular
(IM) at CIDR insertion (day 0), or start of treatment to each donor.
2. Administer IM Follitropin V FSH injections (20 mg/ml) to each donor as follows:
Day 4:

Day 5:

Day 6:

Day 7:

A.M.

2.2 ml

P.M.

2.0 ml

A.M.

2.0 ml

P.M.

1.8 ml

A.M.

1.6ml

P.M.

1.2 ml

A.M.

1.0 ml

Total FSH Dose:

11.8 ml

3. Administer Lutalyse PGF2α injections (5 mg/ml) IM to each donor on day 6 of
treatment.
4. On the P.M. of day 6 of treatment remove the CIDR inserts.
5. Check for estrus and give estradiol-17β at time of AI (AI is performed 12 and 24 hours
post standing estrus).
6. Nonsurgically collect embryos from donors on day 7 post AI.
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APPENDIX B: MEDIA FORMULATIONS AND STOCK SOLUTIONS
PHE STOCK1
Component

Product Number

Company

Amount

1 mM Hypotaurine

H-1384

Sigma

5 ml

2 mM Penicillamine

P-4875

Sigma

5 ml

250 mM
Epinephrine

E-1635

Sigma

2 ml

0.9% Saline

-

-

8 ml

1

Prepare primary stocks of 1 mM hypotaurine (Sigma H-1384) (1.09 mg/10 ml
saline), 2 mM penicillamine (Sigma P-4875) (3 mg/10 ml saline) and 250 mM
epinephrine (Sigma E-1635) [1.83 mg/ 40 ml of the following solution (165 mg
60% Na lactate syrup, 50 mg Na metabisulfite (Sigma S-9000) and 50 ml water].
Epinephrine is easily oxidized by direct light so take precautions to avoid this
problem (wrap in aluminum foil or place in dark container). Sterile filter and
aliquot 100 μl into sterile 0.5 ml microcentrifuge tubes. Store in a light resistant
container at -20°C indefinitely.

HEPARIN STOCK1
Component
Heparin
0.9% Saline

Product Number

Company

H-3149

Sigma

1 mg

-

-

20 ml

1

Amount

Sterile filter and aliquot 100 μl into sterile 0.5 ml microcentrifuge tubes. Store at 20°C indefinitely.
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SPERM – TL1
Component

Product Number

Company

Final (mM)

mg/100 ml

NaCl

S-5886

Sigma

100

582

KCl

P-5405

Sigma

3.1

23

NaHCO3

S-5761

Sigma

25

209

NaH2PO4

S-5011

Sigma

0.29

3.48

HEPES

H-3375

Sigma

10

238

Lactic acid

L-7900

Sigma

21.6

183.4 μl

Phenol red

P-0290

Sigma

1 μl/ml

100 μl

*CaCl2·2H20

C-7902

Sigma

2.1

29

*MgCl2·6H20

M-2393

Sigma

1.5

31

1

Add NaCl, KCl, NaHCO3, NaH2PO4, HEPES, lactic acid, and phenol red
into a beaker. Bring volume to 90ml with ddH2O and dissolve completely.
*CaCl2·2H2O and MgCl2·6H2O should be dissolved in a small amount of ddH2O
before added to other ingredients. Adjust volume to 100ml with ddH2O.
Vacuum-filter into a plastic bottle. Date, label “SP-TL”, and store at 4oC for one
month.
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IVF – TL1
Component

Product Number

Company

Final (mM)

mg/100 ml

NaCl

S-5886

Sigma

114

666

KCl

P-5405

Sigma

3.2

23.5

NaHCO3

S-5761

Sigma

25

210.4

NaH2PO4

S-5011

Sigma

0.34

4.08

Lactic acid

L-7900

Sigma

10

84.92 μl

Phenol red

P-0290

Sigma

1 μl/ml

100 μl

*CaCl2·2H20

C-7902

Sigma

2

30

*MgCl2·6H20

M-2393

Sigma

0.5

10

1

Add NaCl, KCl, NaHCO3, NaH2PO4, lactic acid, and phenol red into a beaker.
Bring volume to 90ml with ddH2O and dissolve completely. *CaCl2·2H2O and
MgCl2·6H2O should be dissolved in a small amount of ddH2O before added to
other ingredients. Adjust volume to 100ml with ddH2O. Vacuum-filter into a
plastic bottle. Date, label “IVF-TL”, and store at 4oC for one month.

115

HEPES – TL1
Component

Product Number

Company

Final (mM)

mg/500 ml

NaCl

S-5886

Sigma

114

3330

KCl

P-5405

Sigma

3.2

120

NaHCO3

S-5761

Sigma

2

84

NaH2PO4

S-5011

Sigma

0.34

20.4

HEPES

H-4034

Sigma

10

1200

Lactic acid

L-7900

Sigma

10

424.6 μl

Phenol red

P-0290

Sigma

1 μl/ml

500 μl

*CaCl2·2H20

C-7902

Sigma

2

150

*MgCl2·6H20

M-2393

Sigma

0.5

50

1

Add NaCl, KCl, NaHCO3, NaH2PO4, HEPES, lactic acid, and phenol red into a
beaker. Bring volume to 480 ml with ddH2O and dissolve completely.
*CaCl2·2H2O and MgCl2·6H2O should be dissolved in a small amount of ddH2O
before added to other ingredients. Adjust volume to 500 ml with ddH2O.
Vacuum-filter into a plastic bottle. Date, label “HEPES-TL”, and store at 4oC for
one month.
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IVF – TALP1
Component

Product Number

Company

BSA, EFAF

A-6003

Sigma

60 mg

IVF-TL

-

-

9.8 ml

Na pyruvate
(20 mM stock)

-

-

100 μl

15140-122

Gibco

100 μl

Pen/Strep

Amount

1

pH should be ~7.4 – do not check! Sterile-filter. Date, label “IVF-TALP”, and
store at 4oC for one week.

HEPES – TALP1
Component

Product Number

Company

A-4503

Sigma

60 mg

HEPES-TL

-

-

20 ml

Na pyruvate
(20 mM stock)

-

-

200 μl

15140-122

Gibco

200 μl

BSA, Fraction V

Pen/Strep

Amount

1

pH should be ~7.4 – do not check! Sterile-filter. Date, label “HEPES-TALP”,
and store at 4oC for one week.

SPERM – TALP1
Component
BSA, Fraction V
SPERM-TL
Na pyruvate
mM stock)
Pen/Strep

(20

Product Number

Company

A-4503

Sigma

60 mg

-

-

9.5 ml

-

-

500 μl

15140-122

Gibco

100 μl

1

Amount

pH should be ~7.4 – do not check! Sterile-filter. Date, label “SP-TALP”, and
store at 4oC for one week.
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HYALURONIDASE SOLUTION1
Component

Product Number

Company

Amount

HEPES-TALP

-

-

10 ml

Hyaluronidase

H-3506

Sigma

10 mg

1

Filter and aliquot 1 ml into 1.5 ml tubes. Solution may be stored at -80oC
indefinitely.

KSOM STOCK1
Component

Product Number

Company

Final (mM)

mg/100 ml

EDTA (add first)

E-5134

Sigma

0.01

100 μl stock

NaCl

S-5886

Sigma

95

555.18

KCl

P-5405

Sigma

2.5

18.5

KH2PO4

P-5655

Sigma

0.35

4.75

MgSO4·7H20

M-1880

Sigma

0.20

4.95

DL-lactic acid

L-7900

Sigma

20.49

174 μl

D-glucose

G-7021

Sigma

0.20

3.6

NaHCO3

S-5761

Sigma

25

210

Pyruvic acid

P-4562

Sigma

0.20

2.2

Phenol red

P-0290

Sigma

1 μl/ml

100 μl

1

Add all components to 90 ml ddH2O and dissolve completely. Dissolve 25 mg
CaCl2 (anhydrous; 1.71 mM) (Sigma C-7902) in about 10 ml of double distilled
water. Add the dissolved CaCl2 to the above ingredients and bring the total to
100 ml with ddH2O. Vacuum filter stock solution into a plastic bottle; store at 4°C
for up to one month.
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KSOMaa MEDIUM1
Component

Product Number

Company

Amount

KSOM Stock

-

-

4.77 ml

L-glutamine

G-8540

Sigma

25 μl stock

BSA Fraction V

A-9647

Sigma

15 mg

15140-122

Gibco

50 μl

B-6766

Sigma

100 μl

M-7145

Sigma

50 μl

Pen/Strep
BME Essential
Amino Acids, 50X
MEM Nonessential
Amino Acids, 100X
1

Made media on day of use; medium should be salmon color. Sterilize the
solution by filtration and store at 4oC for one week.

SOF STOCK1
Component

Product Number

Company

Final (mM)

mg/100 ml

EDTA (add first)

E-5134

Sigma

0.01

100 μl stock

NaCl

S-5886

Sigma

107.7

629.4

KCl

P-5405

Sigma

7.16

53.38

KH2PO4

P-5655

Sigma

1.19

16.2

NaHCO3

S-5761

Sigma

25.07

210.6

DL-lactic acid

L-7900

Sigma

3.3

47.33 μl

*MgCl2·6H2O

M-2393

Sigma

0.49

9.96

*CaCl2·2H2O

C-7902

Sigma

1.71

25.14

Phenol red

P-0290

Sigma

1 μl/ml

100 μl

1

Add all components except CaCl2·2H2O and MgCl2·6H2O to 90 ml ddH2O and
dissolve completely. *Separately, dissolve CaCl2·2H2O into ~5ml ddH2O and
then combine with other ingredients. Separately, dissolve MgCl2·6H2O into ~5ml
ddH2O and then combine with other ingredients. Bring pH to 7.3 (Osmolarity of
~270 mOsm) and volume to 100ml. Vacuum filter stock solution into a plastic
bottle; store at 4°C for up to one month.
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SOFaa MEDIUM1
Component

Product Number

Company

Amount

SOF Stock

-

-

4.542 ml

L-glutamine

G-8540

Sigma

25 μl stock

Na pyruvate

P-4562

Sigma

82.5 μl stock

Glucose

G-7021

Sigma

150 μl stock

BSA EFAF

A-6003

Sigma

15 mg

Pen/Strep

15140-122

Gibco

50 μl

B-6766

Sigma

100 μl

M-7145

Sigma

50 μl

BME Essential
Amino acids, 50X
MEM Nonessential Amino
acids, 100X
1

Made media on day of use; medium should be pink color. Sterilize the solution
by filtration and store at 4oC for one week.

EDTA STOCK1 (0.1 mM)
Component

Product Number

Company

EDTA

E-5134

Sigma

ddH2O

-

-

Amount
3.8 mg
1 ml

1

Do not filter. Make fresh each time.

Na PYRUVATE STOCK1 (20 mM)
Component

Product Number

Company

Pyruvic acid

P-4562

Sigma

22 mg

-

-

10 ml

ddH2O
1

Amount

Sterile filter into aluminum foil wrapped 15 ml tube. Store at 4oC for two months.
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L- GLUTAMINE STOCK1 (200 mM)
Component

Product Number

Company

Amount

L-glutamine

G-8540

Sigma

2.923 g

0.9% Saline

-

-

100 ml

1

Sterile filter into 100 µl aliquots in sterile 0.5 ml microcentrifuge tubes. Store at 20°C indefinitely.

GLUCOSE STOCK1 (50 mM)
Component
D-glucose

Product Number

Company

Amount

G-7021

Sigma

90.08 mg

-

-

ddH2O

10 ml

1

Sterile-filter into 15 ml tube. Store at 4°C for 2 months.

HOECHST STOCK1
Component
MilliQ H2O
Hoechst 33342

Product Number

Company

Amount

-

-

5 ml

H-2261

Sigma

5 mg

1

Make aliquots of 10 μl. Store at 4°C.

0.04% TRITON SOLUTION1
Component
dPBS
Triton X-100

Product Number

Company

14080-055

Gibco

10 ml

T-9284

Sigma

4 μl

1

Store at 4°C.
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Amount

PROPIDIUM IODIDE STOCK1
Component

Product Number

Company

MilliQ Water

-

-

P-4170

Sigma

Propidium Iodide

Amount
1 ml
25 mg

1

Aliquot into Eppendorf tubes, 25μl per tube. Store at -80°C.

iSCRIPT RT MIX
Component

Product Number

Company

iScript Rxn Mix

170-8891

BioRad

4 μl

Reverse
Transcriptase

170-8891

BioRad

1 μl

-

-

170-8891

BioRad

mRNA

H2O

Amount

11 μl (eluted
from beads)
4 μl

dNTP MIX1
Component

Product Number

Company

dATP

1-969-064

Roche

10 μl

dCTP

1-969-064

Roche

10 μl

dGTP

1-969-064

Roche

10 μl

dTTP

1-969-064

Roche

10 μl

H2O2

-

-

60 μl

1

Store at -20°C for 2 to 3 months.
Autoclave the water before use.

2
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Amount

RT-PCR MASTER MASTER MIX (MMM)
Component

Amount
(Per Sample)

Product Number

Company

H2O1

-

-

35 μl

dNTP Mix

-

-

1 μl

10 X PCR Buffer

D-8187

Sigma

5 μl

Jump Start Taq
Polymerase

D-8187

Sigma

2 μl

1

Autoclave the water before use.

RT-PCR MASTER MIX (MM)
Component

Amount
(Per Sample)

Product Number

Company

RT-PCR MMM

-

-

43 μl

Primer 1

-

Invitrogen

1 μl

Primer 2

-

Invitrogen

1 μl

Amount
(Per Sample)

RT-PCR MIX
Component

Product Number

Company

RT-PCR MM

-

-

45 μl

cDNA

-

-

5 μl
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Q-PCR REACTION MIX
Component

Amount
(Per Well)

Product Number

Company

SYBR Green 2X Supermix

170-8882

BioRad

cDNA/Calibrator/ H2O for

-

-

4 μl

H2O1

-

-

6.5 μl

12.5 μl

NT control

1

Autoclave the water before use.

Q-PCR MASTER MIX (MM) FOR ALL 5 GENES
Component

Amount (Per
Sample/Pool)1

Product Number

Company

170-8882

BioRad

65 μl

cDNA/Calibrator/ H2O for
NT control

-

-

20 μl

H2O

-

-

33.8 μl

SYBR Green 2X Supermix

1

Analyzing 5 genes; Multiplied per well values by 5.2 to ensure enough.
Note: To make a mix for all pools of embryos, leave out the cDNA/Calibrator/
H2O for NT and multiply by the number of pools. Again overcompensate for loss
in pipetting. For example, if analyzing 12 pools, multiply by 12.5.

Q-PCR MIX
Amount (Per
Sample/Pool)

Component

Product Number

Company

Q-PCR MM

-

-

23 μl

Primer 1

-

Invitrogen

1 μl

Primer 2

-

Invitrogen

1 μl
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APPENDIX C: EFFECT OF EARLY NUTRITIONAL ENVIRONMENTS ON
PORCINE FETAL AND PLACENTAL DEVELOPMENT
Pig Project Protocol
1. Donor gilts are synchronized and superovulated via Regumate (Intervet Inc.,
Millsboro, DE, USA) and eCG (Section 1) and artificially inseminated.
2. Gilts are sacrificed 2 to 3 days post-insemination and reproductive tracts are collected
for subsequent embryo recovery. Embryos are flushed from the tracts via Betltsville
Embryo Culture Medium (BECM) (Section 2). DNA is also taken from donors for later
parentage microarray analysis. Serum and plasma samples are also obtained from
donor gilts.
3. Collected embryos are allotted to either a high or low glucose North Carolina State
University (NCSU) 23 Medium (Section 3) commonly used in porcine in vitro culture.
4. Embryos are cultured according to treatment for 4 days within the CO2 incubator.
5. Embryos are then surgically transferred ~ 4 to 5 mm below the utero-tubal junction
into the tip of the uterine horn of a recipient(s) sow to allow gestation to proceed.
6. Fetuses should be collected via sacrificing the recipient sow at ~100 days of
gestation. Note: To date, no recipient sow for treatment groups has successfully
established a pregnancy. Fetuses from two control sows have been collected.

Section 1.
250 μg/ml 1500 IU
Estrumate eCG*

50 μg/ml
Cystorelin†

Regumate (days 1-14)
1

Sacrifice gilts and
collect embryo

Check for estrus & breed
14

15

18

Day of Treatment
*Give 24 h post-Estrumate injection.
Give 78 h post-eCG injection.

†
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Section 2.
BECM MEDIUM1
Component

Product Number

Company

Final (mM)

g/1 L

Na lactate
syrup (60%)

L-4263

Sigma

19.3

3.6 ml

Ca lactate·H20

L-4388

Sigma

2.14

0.467

NaCl

S-5886

Sigma

90

5.26

KCl

P-5405

Sigma

8.43

0.36

MgCl2·6H20

M-2393

Sigma

0.54

0.11

NaHCO3

S-5761

Sigma

2.14

0.18

HEPES

H-9136

Sigma

10.91

2.6

Glucose

G-7021

Sigma

0.55

0.1

Mannitol

M-9647

Sigma

11

2

L-glutamine

G-5763

Sigma

1

0.15

Taurine

T-7146

Sigma

7

0.88

Na pyruvate

P-5280

Sigma

0.27

0.03

EDTA

E-6758

Sigma

0.08

0.03

Phenol red

P-5530

Sigma

0.001%

1 ml

Pen/Strep

15140-122

Gibco

1%

10 ml

M-7145

Sigma

1%

10 ml

BME Essential
Amino acids

B-6766

Sigma

2%

20 ml

BSA

A-7906

Sigma

0.1 mg/ml

10

MEM
Nonessential
Amino acids

1

Dissolve each constituent completely in ddH2O in order shown above before
adding next component. Adjust pH to 7.2 with 1N NaOH. Osmotic pressure is
about 280 mOsm. Sterile by vacuum filtration into a plastic bottle, date and initial
bottle. Store at 4°C and use within 10 days.
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Section 3.
NCSU MEDIUM1
Component

Product Number

Company

Final (mM)

mg/100 ml

NaCl

S-5886

Sigma

108.73 (↑G)
113.73 (↓G)

636 (↑G)
665 (↓G)

KCl

P-5405

Sigma

4.78

35.6

NaHCO3

S-5761

Sigma

25.07

210.6

KH2PO4

P-5655

Sigma

1.19

16.2

glucose

G-7021

Sigma

5.55 (↑G)
0.2 (↓G)

100 (↑G)
3.6 (↓G)

L-glutamine

G-8540

Sigma

1

14.6

Taurine

T-8641

Sigma

7

87.6

Hypotaurine

H-1384

Sigma

5

54.6

Pen/Strep

15140-122

Gibco

1%

1 ml

Cysteine

C-7352

Sigma

0.1 mg/ml

10

M-7145

Sigma

1%

1 ml

BME
Essential
Amino acids

B-6766

Sigma

2%

2 ml

BSA

A-7906

Sigma

0.4%

400

Phenol red

P-0290

Sigma

0.001%

100 μl

*CaCl2·2H20

C-7902

Sigma

1.7

25

*MgSO4·7H20

M-1880

Sigma

1.19

29.3

MEM
Nonessential
Amino acids

1

Add all components except Ca+2 and Mg+2 to 90 ml of ddH2O. *CaCl2·2H20 and
MgSO4·7H20 should be dissolved in a small amount of ddH2O before added to
other ingredients. Adjust volume to 100 ml with ddH2O. pH should be 7.4. Sterile
by vacuum filtration into a plastic bottle, date and initial bottle. Store at 4°C and
use within 10 days.
NOTE: BSA type is very important. Also, Pen/Strep is optional
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